ES2590038T3 - Oxazine derivative - Google Patents

Oxazine derivative Download PDF

Info

Publication number
ES2590038T3
ES2590038T3 ES10836054.6T ES10836054T ES2590038T3 ES 2590038 T3 ES2590038 T3 ES 2590038T3 ES 10836054 T ES10836054 T ES 10836054T ES 2590038 T3 ES2590038 T3 ES 2590038T3
Authority
ES
Spain
Prior art keywords
substituted
unsubstituted
alkyl
alkylsulfinyl
acyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES10836054.6T
Other languages
Spanish (es)
Other versions
ES2590038T5 (en
Inventor
Moriyasu Masui
Akihiro Hori
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44145678&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2590038(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Application granted granted Critical
Publication of ES2590038T3 publication Critical patent/ES2590038T3/en
Publication of ES2590038T5 publication Critical patent/ES2590038T5/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/041,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/061,3-Oxazines; Hydrogenated 1,3-oxazines not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/041,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/061,3-Oxazines; Hydrogenated 1,3-oxazines not condensed with other rings
    • C07D265/081,3-Oxazines; Hydrogenated 1,3-oxazines not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5355Non-condensed oxazines and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems

Abstract

Un compuesto de fórmula (1):**Fórmula** en donde el anillo A es un carbociclo sustituido o un heterociclo sustituido o no sustituido, R1 es alquilo sustituido o no sustituido, alquenilo sustituido o no sustituido, alquinilo sustituido o no sustituido, acilo sustituido o no sustituido, ciano, carboxi, alcoxicarbonilo sustituido o no sustituido, alqueniloxicarbonilo sustituido o no sustituido, alquiniloxicarbonilo sustituido o no sustituido o carbamoílo sustituido o no sustituido, tiocarbamoilo sustituido o no sustituido, un grupo carbocíclico sustituido o no sustituido, un grupo heterocíclico sustituido o no sustituido, R2a y R2b son, cada uno independientemente, hidrógeno, alquilo sustituido o no sustituido, acilo sustituido o no sustituido, alcoxicarbonilo sustituido o no sustituido o carbamoílo sustituido o no sustituido, en la que Rza y Rzb son, cada uno independientemente, hidrógeno, halógeno, alquilo sustituido o no sustituido, alquenilo sustituido o no sustituido, alquinilo sustituido o no sustituido, alcoxi sustituido o no sustituido, alqueniloxi sustituido o no sustituido, alquiniloxi sustituido o no sustituido, alquiltio sustituido o no sustituido, alqueniltio sustituido o no sustituido, alquiniltio sustituido o no sustituido, acilo sustituido o no sustituido, carboxi, alcoxicarbonilo sustituido o no sustituido, alqueniloxicarbonilo sustituido o no sustituido, alquiniloxicarbonilo sustituido o no sustituido, amino sustituido o no sustituido, carbamoílo sustituido o no sustituido, tiocarbamoílo sustituido o no sustituido, un grupo carbocíclico sustituido o no sustituido, carbocicliloxi sustituido o no sustituido, carbocicliltio sustituido o no sustituido, carbociclilalquilo sustituido o no sustituido. carbociclilalcoxi sustituido o no sustituido, carbocicliloxicarbonilo sustituido o no sustituido, un grupo heterocíclico sustituido o no sustituido, heterocicliloxi sustituido o no sustituido, heterocicliltio sustituido o no sustituido, heterociclilalquilo sustituido o no sustituido, heterociclilalcoxi no sustituido o sustituido, heterocicliloxicarbonilo sustituido o no sustituido, o Rza y Rzb, junto con el átomo de carbono al que están unidos, pueden formar un carbociclo no aromático sustituido o no sustituido o un heterociclo no aromático sustituido o no sustituido, R3a, R3b, R3c, R4a, R4b y R4c son, cada uno independientemente, hidrógeno, halógeno, hidroxi, alquilo sustituido o no sustituido, alquenilo sustituido o no sustituido, alquinilo sustituido o no sustituido, alcoxi sustituido o no sustituido, alqueniloxi sustituido o no sustituido o alquiniloxi sustituido o no sustituido, alquiltio sustituido o no sustituido, alqueniltio sustituido o no sustituido, alquiniltio sustituido o no sustituido, acilo sustituido o no sustituido, aciloxi sustituido o no sustituido, ciano, nitro, carboxi, alcoxicarbonilo sustituido o no sustituido, alqueniloxicarbonilo sustituido o no sustituido, alquiniloxicarbonilo sustituido o no sustituido, amino sustituido o no sustituido, carbamoílo sustituido o no sustituido, tiocarbamoílo sustituido o no sustituido, sulfamoílo sustituido o no sustituido, alquilsulfinilo sustituido o no sustituido, alquenilsulfinilo sustituido o no sustituido, alquinilsulfinilo sustituido o no sustituido, alquilsulfonilo sustituido o no sustituido, alquenilsulfonilo sustituido o no sustituido, alquinilsulfonilo sustituido o no sustituido, un grupo carbocíclico sustituido o no sustituido, carbocicliloxi sustituido o no sustituido, carbocicliltio sustituido o no sustituido, carbociclilalquilo sustituido o no sustituido, carbociclilalcoxi sustituido o no sustituido, carbocicliloxicarbonilo sustituido o no sustituido, carbociclilsulfinilo sustituido o no sustituido, carbociclilsulfonilo sustituido o no sustituido, un grupo heterocíclico sustituido o no sustituido, heterocicliloxi sustituido o no sustituido, heterocicliltio sustituido o no sustituido, heterociclilalquilo sustituido o no sustituido, heterociclilalcoxi sustituido o no sustituido, heterocicliloxicarbonilo sustituido o no sustituido, heterociclilsulfinilo sustituido o no sustituido o heterociclilsulfonilo sustituido o no sustituido, sustituido, heterocicliloxicarbonilo sustituido o no sustituido, heterociclilsulfinilo sustituido o no sustituido o heterociclilsulfonilo sustituido o no sustituido, R3a y R3b, junto con el átomo de carbono al que están unidos, pueden formar un carbociclo sustituido o no sustituido o un heterociclo sustituido o no sustituido, R4a y R4b, junto con el átomo de carbono al que están unidos, pueden formar un carbociclo sustituido o no sustituido o un heterociclo sustituido o no sustituido, el anillo Q es un carbociclo sustituido o no sustituido, o un heterociclo sustituido o no sustituido, la línea discontinua a, la línea discontinua b y la línea discontinua c significa cada una de forma independiente la presencia o ausencia de un enlace, cuando una línea discontinua a significa la presencia de un enlace, entonces R3b y R4b están ausentes, cuando la línea discontinua b significa la presencia de un enlace, entonces R3c está ausente cuando la línea discontinua c significa la presencia de un enlace, entonces R4c está ausente, Y1 e Y2 son, cada uno independientemente ,-C(R5)(R6)-, -C(R6)>=, -N(R7)-, -N>=, -S-, -SO-, -SO2- u -O-, Y3 e Y4 son, cada uno independientemente, -C(R5)(R6)-, N(R7)-, -S-, -SO-, -SO2- u -O-, R5 y R6 son, cada uno independientemente, hidrógeno, halógeno, hidroxi, alquilo sustituido o no sustituido, alquenilo sustituido o no sustituido, alquinilo sustituido o no sustituido, alcoxi sustituido o no sustituido, alqueniloxi sustituido o no sustituido, alquiniloxi sustituido o no sustituido, alquiltio sustituido o no sustituido, alqueniltio sustituido o no sustituido, alquiniltio sustituido o no sustituido, acilo sustituido o no sustituido, aciloxi sustituido o no sustituido, ciano, nitro, carboxi, alcoxicarbonilo sustituido o no sustituido, alqueniloxicarbonilo sustituido o no sustituido, alquiniloxicarbonilo, amino sustituido o no sustituido, carbamoílo sustituido o no sustituido, tiocarbamoílo sustituido o no sustituido, sulfamoílo sustituido o no sustituido, alquilsulfinilo sustituido o no sustituido, alquenilsulfinilo sustituido o no sustituido, alquinilsulfinilo sustituido o no sustituido, alquilsulfonilo sustituido o no sustituido, alquenilsulfonilo sustituido o no sustituido, alquinilsulfonilo sustituido o no sustituido, un grupo carbocíclico sustituido o no sustituido, carbocicliloxi sustituido o no sustituido, carbocicliltiio sustituido o no sustituido, carbociclilalquilo sustituido o no sustituido, carbociclilalcoxi sustituido o no sustituido, carbocicliloxicarbonilo sustituido o no sustituido, carbociclilsulfinilo sustituido o no sustituido, carbociclilsulfonilo sustituido o no sustituido, un grupo heterocíclico sustituido o no sustituido, heterocicliloxi sustituido o no sustituido, heterocicliltio sustituido o no sustituido, heterociclilalquilo sustituido o no sustituido, heterociclilalcoxi sustituido o no sustituido, heterocicliloxicarbonilo sustituido o no sustituido, heterociclilsulfinilo sustituido o no sustituido, heterociclilsulfonilo sustituido o no sustituido y R7 es hidrógeno, halógeno, hidroxi, alquilo sustituido o no sustituido, alquenilo sustituido o no sustituido, alquinilo sustituido o no sustituido, alcoxi sustituido o no sustituido, alqueniloxi sustituido o no sustituido, alquiniloxi sustituido o no sustituido, acilo sustituido o no sustituido, aciloxi sustituido o no sustituido, ciano, nitro, carboxi, alcoxicarbonilo sustituido o no sustituido, alqueniloxicarbonilo sustituido o no sustituido, alquiniloxicarbonilo sustituido o no sustituido, alquilsulfinilo sustituido o no sustituido, alquenilsulfinilo sustituido o no sustituido, alquinilsulfinilo sustituido o no sustituido, alquilsulfonilo sustituido o no sustituido, alquenilsulfonilo sustituido o no sustituido, alquinilsulfonilo sustituido o no sustituido, carbamoílo sustituido o no sustituido, tiocarbamoílo sustituido o no sustituido, sulfamoílo sustituido o no sustituido, amino sustituido o no sustituido, un grupo carbocíclico sustituido o no sustituido, carbocicliloxi sustituido o no sustituido, carbocicliltio sustituido o no sustituido, carbociclilalquilo sustituido o no sustituido, carbociclilalcoxi sustituido o no sustituido, carbocicliloxicarbonilo sustituido o no sustituido, carbociclilsulfinilo sustituido o no sustituido, carbociclilsulfonilo sustituido o no sustituido, un grupo heterocíclico sustituido o no sustituido, heterocicliloxi sustituido o no sustituido, heterocicliltio sustituido o no sustituido, heterociclilalquilo sustituido o no sustituido, heterociclilalcoxi sustituido o no sustituido, heterocicliloxicarbonilo sustituido o no sustituido, heterociclilsulfinilo sustituido o no sustituido o heterociclilsulfonilo sustituido o no sustituido, los sustituyentes de "carbociclo sustituido" y "heterociclo sustituido o no sustituido" en el anillo A, el anillo A' y el anillo B son, si están presentes, uno o más sustituyentes seleccionados de un grupo seleccionado del grupo sustituyente α; en donde el grupo sustituyente α es un grupo que consiste en halógeno, hidroxi, alcoxi, haloalcoxi, hidroxialcoxi, alcoxialcoxi, acilo, aciloxi, carboxi, alcoxicarbonilo, amino, acilamino, alquilamino, imino, hidroxiimino, alcoxiimino, alquiltio, carbamoilo, alquilcarbamoilo, hidroxialquilcarbamoílo, sulfamoílo, alquilsulfamoilo, alquilsulfinilo, alquilsulfonilamino, alquilsulfonilalquilamino, alquilsulfonilimino, alquilsulfinilamino, alquilsulfinilalquilamino, alquilsulfinilimino, ciano, nitro, un grupo carbocíclico y un grupo heterocíclico, cada uno de los cuales carbociclo y heterociclo está opcionalmente sustituido con uno o más sustituyentes seleccionados de halógeno, alquilo, hidroxi y alcoxi: alquilo sustituido con uno o más grupos seleccionados del grupo sustituyente α, hidroxiimino y alcoxiimino, o aA compound of formula (1): ** Formula ** wherein ring A is a substituted carbocycle or a substituted or unsubstituted heterocycle, R1 is substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, substituted or unsubstituted acyl, cyano, carboxy, substituted or unsubstituted alkoxycarbonyl, substituted or unsubstituted alkenyloxycarbonyl, substituted or unsubstituted alkynyloxycarbonyl or substituted or unsubstituted carbamoyl, substituted or unsubstituted thiocarbamoyl, a substituted or unsubstituted carbocyclic group, a group substituted or unsubstituted heterocyclic, R2a and R2b are each independently hydrogen, substituted or unsubstituted alkyl, substituted or unsubstituted acyl, substituted or unsubstituted alkoxycarbonyl or substituted or unsubstituted carbamoyl, in which Rza and Rzb are each one independently, hydrogen, halogen, substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl, alkyne substituted or unsubstituted yl, substituted or unsubstituted alkoxy, substituted or unsubstituted alkenyloxy, substituted or unsubstituted alkynyloxy, substituted or unsubstituted alkylthio, substituted or unsubstituted alkenylthio, substituted or unsubstituted alkynylthio, substituted or unsubstituted acyl, carboxy, substituted or unsubstituted alkoxycarbonyl, substituted or unsubstituted alkenyloxycarbonyl, substituted or unsubstituted alkynyloxycarbonyl, substituted or unsubstituted amino, substituted or unsubstituted carbamoyl, substituted or unsubstituted thiocarbamoyl, a substituted or unsubstituted carbocyclic group, substituted or unsubstituted carbocyclyloxy substituted or unsubstituted carbocyclyl, substituted or unsubstituted carbocyclyl alkyl. substituted or unsubstituted carbocyclylalkoxy, substituted or unsubstituted carbocyclyloxycarbonyl, a substituted or unsubstituted heterocyclic group, substituted or unsubstituted heterocyclyloxy, substituted or unsubstituted heterocyclylthio, substituted or unsubstituted heterocyclylalkyl, unsubstituted heterocyclic or unsubstituted heterocyclyl or Rza and Rzb, together with the carbon atom to which they are attached, can form a substituted or unsubstituted non-aromatic carbocycle or a substituted or unsubstituted non-aromatic heterocycle, R3a, R3b, R3c, R4a, R4b and R4c are, each one independently, hydrogen, halogen, hydroxy, substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, substituted or unsubstituted alkoxy, substituted or unsubstituted alkenyloxy or substituted or unsubstituted alkynyloxy, substituted or unsubstituted alkylthio , substituted or unsubstituted alkenylthio, substituted alkylthio unsubstituted or substituted, substituted or unsubstituted acyl, substituted or unsubstituted acyloxy, cyano, nitro, carboxy, substituted or unsubstituted alkoxycarbonyl, substituted or unsubstituted alkenyloxycarbonyl, substituted or unsubstituted alkynyloxycarbonyl, substituted or unsubstituted amino, substituted carbamoyl or unsubstituted, substituted or unsubstituted thiocarbamoyl, substituted or unsubstituted sulfamoyl, substituted or unsubstituted alkylsulfinyl, substituted or unsubstituted alkenylsulfinyl, substituted or unsubstituted alkylsulfinyl, substituted or unsubstituted alkylsulfonyl, substituted or unsubstituted alkenylsulfonyl, alkylsulfonyl , a substituted or unsubstituted carbocyclic group, substituted or unsubstituted carbocyclyloxy, substituted or unsubstituted carbocyclylthio, substituted or unsubstituted carbocyclylalkyl, substituted or unsubstituted carbocyclylalkoxy, substituted or unsubstituted carbocyclyloxycarbonyl, substituted carbocyclylsulfinyl or unsubstituted, substituted or unsubstituted carbocyclylsulfonyl, a substituted or unsubstituted heterocyclic group, substituted or unsubstituted heterocyclyloxy, substituted or unsubstituted heterocyclylthio, substituted or unsubstituted heterocyclylalkyl, substituted or unsubstituted heterocyclyloxycarbonyloxycarbonyloxy or unsubstituted or substituted or unsubstituted heterocyclylsulfonyl, substituted, unsubstituted or substituted heterocyclyloxycarbonyl, substituted or unsubstituted heterocyclylsulfinyl or substituted or unsubstituted heterocyclylsulfonyl, R3a and R3b, together with the carbon atom to which they are attached, can form a substituted carbocycle or unsubstituted or a substituted or unsubstituted heterocycle, R4a and R4b, together with the carbon atom to which they are attached, can form a substituted or unsubstituted carbocycle or a substituted or unsubstituted heterocycle, the Q ring is a substituted carbocycle or no substitute uido, or a substituted or unsubstituted heterocycle, the broken line a, the broken line b and the broken line c each independently means the presence or absence of a link, when a broken line a means the presence of a link, then R3b and R4b are absent, when the dashed line b means the presence of a link, then R3c is absent when the dashed line c means the presence of a link, then R4c is absent, Y1 and Y2 are, each independently, -C (R5) (R6) -, -C (R6)> =, -N (R7) -, -N> =, -S-, -SO-, -SO2- or -O-, Y3 and Y4 are, each one independently, -C (R5) (R6) -, N (R7) -, -S-, -SO-, -SO2- or -O-, R5 and R6 are each independently hydrogen, halogen, hydroxy, substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, substituted or unsubstituted alkoxy, substituted or unsubstituted alkenyloxy, substituted or unsubstituted alkynyloxy, alkyl substituted or unsubstituted thio, substituted or unsubstituted alkenylthio, substituted or unsubstituted alkynylthio, substituted or unsubstituted acyl, substituted or unsubstituted acyloxy, cyano, nitro, carboxy, substituted or unsubstituted alkoxycarbonyl, substituted or unsubstituted alkenyloxycarbonyl, alkynyloxycarbonyl, substituted or unsubstituted amino, substituted or unsubstituted carbamoyl, substituted or unsubstituted thiocarbamoyl, substituted or unsubstituted sulfamoyl, substituted or unsubstituted alkylsulfinyl, substituted or unsubstituted alkenylsulfinyl, substituted or unsubstituted alkylsulfinyl, substituted or unsubstituted alkylsulphonyl, alkenyl or unsubstituted, substituted or unsubstituted alkylsulfonyl, a substituted or unsubstituted carbocyclic group, substituted or unsubstituted carbocyclyloxy, substituted or unsubstituted carbocyclylthio, substituted or unsubstituted carbocyclylalkyl, substituted or unsubstituted carbocyclylalkoxy, carbocyclyloxycarbon substituted or unsubstituted ilo, substituted or unsubstituted carbocyclylsulfinyl, substituted or unsubstituted carbocyclylsulfonyl, a substituted or unsubstituted heterocyclic group, substituted or unsubstituted heterocyclyloxy, substituted or unsubstituted heterocyclylthio, substituted or unsubstituted heterocyclyl, substituted heterocyclyl substituted or unsubstituted heterocyclyloxycarbonyl, substituted or unsubstituted heterocyclylsulfinyl, substituted or unsubstituted heterocyclylsulfonyl and R7 is hydrogen, halogen, hydroxy, substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, substituted or unsubstituted alkoxy, substituted or unsubstituted alkenyloxy, substituted or unsubstituted alkynyloxy, substituted or unsubstituted acyl, substituted or unsubstituted acyloxy, cyano, nitro, carboxy, substituted or unsubstituted alkoxycarbonyl, substituted or unsubstituted alkenyloxycarbonyl, substituted alkyloxycarbonyl oo unsubstituted, substituted or unsubstituted alkylsulfinyl, substituted or unsubstituted alkenylsulfinyl, substituted or unsubstituted alkylsulfinyl, substituted or unsubstituted alkylsulphonyl, substituted or unsubstituted alkenylsulfonyl, substituted or unsubstituted alkylsulfonyl, substituted or unsubstituted carbamoyl, thio substituted, substituted or unsubstituted sulfamoyl, substituted or unsubstituted amino, a substituted or unsubstituted carbocyclic group, substituted or unsubstituted carbocyclyloxy, substituted or unsubstituted carbocyclylthio, substituted or unsubstituted carbocyclylalkyl, substituted or unsubstituted carbocyclylalkoxy, unsubstituted carbocyclyloxy substituted, substituted or unsubstituted carbocyclylsulfinyl, substituted or unsubstituted carbocyclylsulfonyl, a substituted or unsubstituted heterocyclic group, substituted or unsubstituted heterocyclyloxy, substituted or unsubstituted heterocyclylthio, substituted or heterocyclyl alkyl unsubstituted, substituted or unsubstituted heterocyclylalkoxy, substituted or unsubstituted heterocyclyloxycarbonyl, substituted or unsubstituted heterocyclylsulfinyl or substituted or unsubstituted heterocyclylsulfonyl, substituents of "substituted carbocycle" and "substituted or unsubstituted heterocycle" in ring A, ring A 'and ring B are, if present, one or more substituents selected from a group selected from the substituent group α; wherein the substituent group α is a group consisting of halogen, hydroxy, alkoxy, haloalkoxy, hydroxyalkoxy, alkoxyalkoxy, acyl, acyloxy, carboxy, alkoxycarbonyl, amino, acylamino, alkylamino, imino, hydroxyimino, alkoxyimino, alkylthio, carbamoyl, alkylcarbamoyl, hydroxyalkylcarbamoyl, sulfamoyl, alkylsulfamoyl, alkylsulfinyl, alkylsulphonylamino, alkylsulfonylalkyl amino, alkylsulfonylimino, alkylsulfinylamino, alkylsulfinyl alkylamino, alkylsulfinylimino, cyano, nitro, a carbocyclic group and a heterocyclic groups with one or more of which are substituted for one or more of which one is selected from each one halogen, alkyl, hydroxy and alkoxy: alkyl substituted with one or more groups selected from the substituent group α, hydroxyimino and alkoxyimino, or

Description

imagen1image 1

imagen2image2

imagen3image3

imagen4image4

imagen5image5

imagen6image6

imagen7image7

5 5

10 10

15 fifteen

20 twenty

25 25

30 30

35 35

40 40

45 Four. Five

Y1 e Y2 son, cada uno independientemente ,-C(R5)(R6)-, -C(R5)=, -N(R7)-, -N=, -S-, -SO-, -SO2-u -O-, Y3 e Y4 son, cada uno independientemente, -C(R5)(R6)-, -C(R5)=, -N(R7)-, -S-, -SO-, -SO2-u -O-, R5 y R6 son, cada uno independientemente, hidrógeno, halógeno, hidroxi, alquilo sustituido o no sustituido, alquenilo sustituido o no sustituido, alquinilo sustituido o no sustituido, alcoxi sustituido o no sustituido, alqueniloxi sustituido o no sustituido alquiniloxi sustituido o no sustituido, alquiltio sustituido o no sustituido, alqueniltio sustituido o no sustituido, alquiniltio sustituido o no sustituido, acilo sustituido o no sustituido, aciloxi sustituido o no sustituido, ciano, nitro, carboxi, alcoxicarbonilo sustituido o no sustituido, alqueniloxicarbonilo sustituido o no sustituido, alquiniloxicarbonilo sustituido o no sustituido, amino sustituido o no sustituido, carbamoílo sustituido o no sustituido, tiocarbamoílo sustituido o no sustituido, sulfamoílo sustituido o no sustituido, alquilsulfinilo sustituido o no sustituido, alquenilsulfinilo sustituido o no sustituido, alquinilsulfinilo sustituido o no sustituido, alquilsulfonilo sustituido o no sustituido, alquenilsulfonilo sustituido o no sustituido, alquinilsulfonilo sustituido o no sustituido, un grupo carbocíclico sustituido o no sustituido, carbocicliloxi sustituido o no sustituido, carbocicliltio sustituido o no sustituido, carbocicliloxicarbonilo sustituido o no sustituido, carbociclilsulfinilo sustituido o no sustituido, carbociclilsulfonilo sustituido o no sustituido, un grupo heterocíclico sustituido o no sustituido, heterocicliloxi sustituido o no sustituido, heterocicliltio sustituido o no sustituido, heterocicliloxicarbonilo sustituido o no sustituido, heterociclilsulfinilo sustituido o no sustituido, heterociclilsulfonilo sustituido o no sustituido, y R7 es hidrógeno, halógeno, alquilo sustituido o no sustituido, alquenilo sustituido o no sustituido, alquinilo sustituido o no sustituido, alcoxi sustituido o no sustituido, alqueniloxi sustituido o no sustituido, alquiniloxi sustituido o no sustituido, acilo sustituido o no sustituido, aciloxi sustituido o no sustituido, ciano, nitro, carboxi, alcoxicarbonilo sustituido o no sustituido, alqueniloxicarbonilo sustituido o no sustituido, alquiniloxicarbonilo sustituido o no sustituido, alquilsulfinilo sustituido o no sustituido, alquenilsulfinilo sustituido o no sustituido, alquinilsulfinilo sustituido Y1 and Y2 are each independently -C (R5) (R6) -, -C (R5) =, -N (R7) -, -N =, -S-, -SO-, -SO2-u - O-, Y3 and Y4 are each independently -C (R5) (R6) -, -C (R5) =, -N (R7) -, -S-, -SO-, -SO2-u -O -, R5 and R6 are each independently hydrogen, halogen, hydroxy, substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, substituted or unsubstituted alkoxy, substituted or unsubstituted alkynyloxy substituted, substituted or unsubstituted alkylthio, substituted or unsubstituted alkenylthio, substituted or unsubstituted alkynylthio, substituted or unsubstituted acyl, substituted or unsubstituted acyloxy, cyano, nitro, carboxy, substituted or unsubstituted alkoxycarbonyl, substituted or unsubstituted alkenyloxycarbonyl, substituted or unsubstituted alkynyloxycarbonyl, substituted or unsubstituted amino, substituted or unsubstituted carbamoyl, substituted or unsubstituted thiocarbamoyl, substituted or non-substituted sulfamoyl ituido, substituted or unsubstituted alkylsulfinyl, substituted or unsubstituted alkenylsulfinyl, substituted or unsubstituted alkylsulfinyl, substituted or unsubstituted alkylsulfonyl, substituted or unsubstituted alkenylsulfonyl, substituted or unsubstituted alkylsulfonyl, a substituted or unsubstituted carbocyclic group, carbocyclic substituted, substituted or unsubstituted carbocyclylthio, substituted or unsubstituted carbocyclyloxycarbonyl, substituted or unsubstituted carbocyclylsulfinyl, substituted or unsubstituted carbocyclylsulfonyl, a substituted or unsubstituted heterocyclic group, substituted or unsubstituted heterocyclyloxy substituted or unsubstituted heterocyclyloxy substituted, substituted or unsubstituted heterocyclylsulfinyl, substituted or unsubstituted heterocyclylsulfonyl, and R7 is hydrogen, halogen, substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl or, substituted or unsubstituted alkoxy, substituted or unsubstituted alkenyloxy, substituted or unsubstituted alkynyloxy, substituted or unsubstituted acyl, substituted or unsubstituted acyloxy, cyano, nitro, carboxy, substituted or unsubstituted alkoxycarbonyl, substituted or unsubstituted alkenyloxycarbonyl, substituted or unsubstituted alkynyloxycarbonyl, substituted or unsubstituted alkylsulfinyl, substituted or unsubstituted alkenylsulfinyl, substituted alkylsulfinyl

o no sustituido, alquilsulfonilo sustituido o no sustituido, alquenilsulfonilo sustituido o no sustituido, alquinilsulfonilo sustituido o no sustituido, carbamoílo sustituido o no sustituido, tiocarbamoílo sustituido o no sustituido, sulfamoílo sustituido o no sustituido, amino sustituido o no sustituido, un grupo carbocíclico sustituido o no sustituido, carbocicliloxi sustituido o no sustituido, carbocicliloxicarbonilo sustituido o no sustituido, carbociclilsulfinilo sustituido or unsubstituted, substituted or unsubstituted alkylsulfonyl, substituted or unsubstituted alkenylsulfonyl, substituted or unsubstituted alkylsulfonyl, substituted or unsubstituted carbamoyl, substituted or unsubstituted thiocarbamoyl, substituted or unsubstituted sulfamoyl, a substituted carbocyclic group or unsubstituted, substituted or unsubstituted carbocyclyloxy, substituted or unsubstituted carbocyclyloxycarbonyl, substituted carbocyclylsulfinyl

o no sustituido, carbociclilsulfonilo sustituido o no sustituido, un grupo heterocíclico sustituido o no sustituido, heterocicliloxi sustituido o no sustituido, heterocicliloxicarbonilo sustituido o no sustituido, heterociclilsulfinilo sustituido o no sustituido, heterociclilsulfonilo sustituido o no sustituido, con exclusión de los compuestos en donde or unsubstituted, substituted or unsubstituted carbocyclylsulfonyl, a substituted or unsubstituted heterocyclic group, substituted or unsubstituted heterocyclyloxy, substituted or unsubstituted heterocyclyloxycarbonyl, substituted or unsubstituted heterocyclylsulfinyl, substituted or unsubstituted heterocyclylsulfonyl, excluding the compounds

imagen8image8

[Fórmula Química 12] [Chemical Formula 12]

imagen9image9

en el que el anillo A' y el anillo B son, cada uno independientemente, un carbociclo sustituido o no sustituido o un heterociclo sustituido o no sustituido, Z es -L1-N(R8)-L2-, L1 y L2 son, cada uno independientemente, un enlace, alquileno sustituido o no sustituido, alquenileno sustituido o no sustituido o alquinileno sustituido o no sustituido; y R8 es hidrógeno, alquilo sustituido o no sustituido, alquenilo sustituido o no sustituido, alquinilo sustituido o no sustituido, acilo sustituido o no sustituido, su sal farmacéuticamente aceptable o un solvato del mismo. Cuando Z es "-L1-N(R8)-L2-", entonces "L1” se une al anillo B y “L2" se une al anillo A’, respectivamente. wherein ring A 'and ring B are each independently a substituted or unsubstituted carbocycle or a substituted or unsubstituted heterocycle, Z is -L1-N (R8) -L2-, L1 and L2 are, each one independently, a bond, substituted or unsubstituted alkylene, substituted or unsubstituted alkenylene or substituted or unsubstituted alkynylene; and R8 is hydrogen, substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, substituted or unsubstituted acyl, its pharmaceutically acceptable salt or a solvate thereof. When Z is "-L1-N (R8) -L2-", then "L1" joins ring B and "L2" joins ring A ', respectively.

(2) El compuesto de acuerdo con cualquiera de los puntos (1), (1-1) y (1-2), en el que el anillo A es [Fórmula Química 13] (2) The compound according to any of items (1), (1-1) and (1-2), in which ring A is [Chemical Formula 13]

9 9

imagen10image10

imagen11image11

imagen12image12

5 5

10 10

15 fifteen

20 twenty

25 25

30 30

35 35

40 40

(10) (10)
El compuesto de acuerdo con uno cualquiera de los puntos (1), (1-1), (1-2), (2) a (4), (5-1) a (5-6) y (6) a (9), en el que R2a y R2b son ambos hidrógeno, su sal farmacéuticamente aceptable o un solvato del mismo. The compound according to any one of items (1), (1-1), (1-2), (2) to (4), (5-1) to (5-6) and (6) to (9), wherein R2a and R2b are both hydrogen, its pharmaceutically acceptable salt or a solvate thereof.

(11) (eleven)
Una composición farmacéutica que comprende el compuesto de acuerdo con uno cualquiera de los puntos (1), (1-1), (1-2), (2) a (4), (5-1) a (5-6) y (6) a (10), su sal farmacéuticamente aceptable o un solvato del mismo como un ingrediente activo. A pharmaceutical composition comprising the compound according to any one of items (1), (1-1), (1-2), (2) to (4), (5-1) to (5-6) and (6) to (10), its pharmaceutically acceptable salt or a solvate thereof as an active ingredient.

(12) (12)
Una composición farmacéutica que tiene actividad inhibidora de BACE1, que comprende el compuesto de acuerdo con uno cualquiera de los puntos (1), (1-1), (1-2), (2) a (4), (5-1) a (5-6) y (6) a (10), su sal farmacéuticamente aceptable o un solvato del mismo como un ingrediente activo. A pharmaceutical composition having BACE1 inhibitory activity, which comprises the compound according to any one of items (1), (1-1), (1-2), (2) to (4), (5-1 ) to (5-6) and (6) to (10), its pharmaceutically acceptable salt or a solvate thereof as an active ingredient.

(14) (14)
El compuesto de acuerdo con uno cualquiera de los puntos (1), (1-1), (1-2), (2) a (4), (5-1) a (5-6) y (6) a (10), su sal farmacéuticamente aceptable o un solvato del mismo para uso en un método para inhibir la actividad de BACE1. The compound according to any one of items (1), (1-1), (1-2), (2) to (4), (5-1) to (5-6) and (6) to (10), its pharmaceutically acceptable salt or a solvate thereof for use in a method to inhibit the activity of BACE1.

(15) (fifteen)
Uso de un compuesto de acuerdo con uno cualquiera de los puntos (1), (1-1), (1-2), (2) a (4), (5-1) a (5-6) y (6) a (10), su sal farmacéuticamente aceptable, o solvato del mismo para la fabricación de un medicamento para inhibir la actividad de BACE1. Use of a compound according to any one of items (1), (1-1), (1-2), (2) to (4), (5-1) to (5-6) and (6 ) to (10), its pharmaceutically acceptable salt, or solvate thereof for the manufacture of a medicament to inhibit the activity of BACE1.

(17) (17)
Uso de un compuesto de acuerdo con uno cualquiera de los puntos (1), (1-1), (1-2), (2) a (4), (5-1) a (5-6) y (6) a (10), su sal farmacéuticamente aceptable, o solvato del mismo para la fabricación de un medicamento para tratar o prevenir enfermedades inducidas por la producción, la secreción o la deposición de proteínas β amiloide. Use of a compound according to any one of items (1), (1-1), (1-2), (2) to (4), (5-1) to (5-6) and (6 ) to (10), its pharmaceutically acceptable salt, or solvate thereof for the manufacture of a medicament for treating or preventing diseases induced by the production, secretion or deposition of amyloid β proteins.

(18) (18)
Un compuesto de acuerdo con uno cualquiera de los puntos (1), (1-1), (1-2), (2) a (4), (5-1) a (5-6) y (6) a (10), su sal farmacéuticamente aceptable, o solvato del mismo para uso en el tratamiento o la prevención de enfermedades inducidas por la producción, la secreción o la deposición de proteínas β amiloide. A compound according to any one of items (1), (1-1), (1-2), (2) to (4), (5-1) to (5-6) and (6) to (10), its pharmaceutically acceptable salt, or solvate thereof for use in the treatment or prevention of diseases induced by the production, secretion or deposition of amyloid β proteins.

(20) (twenty)
Uso de un compuesto de acuerdo con uno cualquiera de los puntos (1), (1-1), (1-2), (2) a (4), (5-1) a (5-6) y (6) a (10), su sal o solvato farmacéuticamente aceptable del mismo para fabricar un medicamento para tratar o prevenir la enfermedad de Alzheimer. Use of a compound according to any one of items (1), (1-1), (1-2), (2) to (4), (5-1) to (5-6) and (6 ) to (10), your pharmaceutically acceptable salt or solvate thereof to make a medicament for treating or preventing Alzheimer's disease.

(21) (twenty-one)
Un compuesto de acuerdo con uno cualquiera de los puntos (1), (1-1), (1-2), (2) a (4), (5-1) a (5-6) y (6) a (10), su sal o solvato farmacéuticamente aceptable del mismo para uso en el tratamiento o la prevención de la enfermedad de Alzheimer. A compound according to any one of items (1), (1-1), (1-2), (2) to (4), (5-1) to (5-6) and (6) to (10), its pharmaceutically acceptable salt or solvate thereof for use in the treatment or prevention of Alzheimer's disease.

(22) (22)
Un método, un sistema, un aparato, un kit o similares para la fabricación del compuesto de acuerdo con uno cualquiera de los puntos (1), (1-1), (1-2), (2) a (4) , (5-1) a (5-6) y (6) a (10), su sal farmacéuticamente aceptable o un solvato del mismo. A method, a system, an apparatus, a kit or the like for the manufacture of the compound according to any one of items (1), (1-1), (1-2), (2) to (4), (5-1) to (5-6) and (6) to (10), its pharmaceutically acceptable salt or a solvate thereof.

(23) (2. 3)
Un método, un sistema, un aparato, un kit o similares para preparar una composición farmacéutica que comprende el compuesto de acuerdo con uno cualquiera de los puntos (1), (1-1), (1-2), (2) a (4), (5-1) a (5-6) y (6) a (10), su sal farmacéuticamente aceptable o un solvato del mismo. A method, a system, an apparatus, a kit or the like to prepare a pharmaceutical composition comprising the compound according to any one of items (1), (1-1), (1-2), (2) a (4), (5-1) to (5-6) and (6) to (10), its pharmaceutically acceptable salt or a solvate thereof.

(25) (25)
Una composición farmacéutica de acuerdo con el punto (11) ó (12) para el tratamiento o la prevención de una enfermedad inducida por la producción, secreción o deposición de proteínas β amiloide. A pharmaceutical composition according to item (11) or (12) for the treatment or prevention of a disease induced by the production, secretion or deposition of amyloid β proteins.

(26) (26)
Una composición farmacéutica de acuerdo con el punto (11) ó (12) para tratar o prevenir la enfermedad de Alzheimer. [Efecto de la Invención]. A pharmaceutical composition according to item (11) or (12) to treat or prevent Alzheimer's disease. [Effect of the Invention].

El compuesto de la presente invención es útil como un agente para tratar o prevenir la enfermedad inducida por la producción, secreción o deposición de proteínas amiloide β, tales como la enfermedad de Alzheimer. [Modo de Llevar a cabo la Invención] The compound of the present invention is useful as an agent for treating or preventing disease induced by the production, secretion or deposition of β-amyloid proteins, such as Alzheimer's disease. [How to Carry Out the Invention]

En la memoria descriptiva, el "halógeno" incluye flúor, cloro, bromo y yodo. In the specification, the "halogen" includes fluorine, chlorine, bromine and iodine.

13 5 13 5

10 10

15 fifteen

20 twenty

25 25

30 30

35 35

40 40

En la memoria descriptiva, el "alquilo" incluye alquilo lineal o ramificado de un número de carbonos de 1 a 15, por ejemplo un número de carbonos de 1 a 10, por ejemplo un número de carbonos de 1 a 6 y, por ejemplo, un número de carbonos de 1 a 3. Ejemplos incluyen metilo, etilo, n-propilo, isopropilo, n-butilo, isobutilo, sec.-butilo, terc.-butilo, n-pentilo, isopentilo, neopentilo, hexilo, isohexilo, n-heptilo, isoheptilo, n-octilo, isooctilo, n-nonilo y n-decilo. In the specification, the "alkyl" includes linear or branched alkyl of a number of carbons from 1 to 15, for example a number of carbons from 1 to 10, for example a number of carbons from 1 to 6 and, for example, a number of carbons from 1 to 3. Examples include methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec.-butyl, tert-butyl, n-pentyl, isopentyl, neopentyl, hexyl, isohexyl, n -heptyl, isoheptyl, n-octyl, isooctyl, n-nonyl and n-decyl.

Las porciones alquilo en "alcoxi", "haloalquilo", "hidroxialquilo", "haloalcoxi", "hidroxi-alcoxi", "alcoxicarbonilo", "haloalcoxicarbonilo", "alquilamino", "aminoalquilo", "alcoxialcoxi", "alcoxialqueniloxi", "alcoxialquinilo", "alquilcarbonilo", "carbamoílo", "hidroxialquilcarbamoílo", "alcoxiimino", "alquiltio", "alquilsulfonilo", "alquilsulfonilamino", "alquilsulfonilalquilamino", "alquilsulfonilimino", "alquilsulfinilamino", "alquilsulfinilalquilamino", "alquilsulfinilimino", "alquilsulfamoilo", "alquilsulfinilo", "carbociclilalquilo", "carbociclilalcoxi", "carbociclilalcoxicarbonilo", "carbociclilalquilamino", "carbociclilalquilcarbamoílo", "cicloalquilalquilo", "cicloalquilalcoxi", "cicloalquilalquilamino", "cicloalquilalcoxicarbonilo", "cicloalquilalquilcarbamoílo", "arilalquilo", "arilalcoxi", "arilalquilamino", "arilalcoxicarbonilo", "arilalquilcarbamoílo", "heterociclilalquilo", "heterociclilalcoxi", "heterociclilalquilamino", "heterociclilalcoxicarbonilo" y "heterociclilalquilcarbamoílo" son los mismos que el "alquilo" anterior. The alkyl portions in "alkoxy", "haloalkyl", "hydroxyalkyl", "haloalkoxy", "hydroxy-alkoxy", "alkoxycarbonyl", "haloalkoxycarbonyl", "alkylamino", "aminoalkyl", "alkoxyalkoxy", "alkoxyalkenyloxy", "alkoxyalkynyl", "alkylcarbonyl", "carbamoyl", "hydroxyalkylcarbamoyl", "alkoxyimino", "alkylthio", "alkylsulfonyl", "alkylsulfonylamino", "alkylsulfonylalkylamino", "alkylsulfonylimino", "alkylsulfinylaminolamino" "," alkylsulfamoyl "," alkylsulfinyl "," carbocyclylalkyl "," carbocyclylalkoxy "," carbocyclylalkoxycarbonyl "," carbocyclylalkylamino "," carbocyclylalkylcarbamoyl "," cycloalkylalkyl "," cycloalkylalkyl "alkyloalkyl" cycloalkylalkyl " "arylalkyl", "arylalkoxy", "arylalkylamino", "arylalkoxycarbonyl", "arylalkylcarbamoyl", "heterocyclylalkyl", "heterocyclylalkoxy", "heterocyclylalkylamino", "heterocyclylalkoxycarbonyl" and "heterocyclic "alkylcarbamoyl" are the same as the "alkyl" above.

"Alquilo sustituido o no sustituido" puede estar sustituido con uno o más sustituyentes seleccionados de un grupo sustituyente α. "Substituted or unsubstituted alkyl" may be substituted with one or more substituents selected from an α substituent group.

Tal como se utiliza en esta memoria, el grupo sustituyente α es un grupo que consiste en halógeno, hidroxi, alcoxi, haloalcoxi, hidroxialcoxi, alcoxialcoxi, acilo, aciloxi, carboxi, alcoxicarbonilo, amino, acilamino, alquilamino, imino, hidroxiimino, alcoxiimino, alquiltio, carbamoilo, alquilcarbamoilo, hidroxialquilcarbamoílo, sulfamoilo, alquilsulfamoilo, alquilsulfinilo, alquilsulfonilamino, alquilsulfonilalquilamino, alquilsulfonilimino, alquilsulfinilamino, alquilsulfinilalquilamino, alquilsulfinilimino, ciano, nitro, un grupo carbocíclico y un grupo heterocíclico, cada uno de los cuales carbociclo y heterociclo está opcionalmente sustituido con uno o más sustituyentes seleccionados de halógeno, alquilo, hidroxi y alcoxi. As used herein, the substituent group α is a group consisting of halogen, hydroxy, alkoxy, haloalkoxy, hydroxyalkoxy, alkoxyalkoxy, acyl, acyloxy, carboxy, alkoxycarbonyl, amino, acylamino, alkylamino, imino, hydroxyimino, alkoxyimino, alkylthio, carbamoyl, alkylcarbamoyl, hydroxyalkylcarbamoyl, sulfamoyl, alkylsulfamoyl, alkylsulfinyl, alkylsulfonylamino, alkylsulfonylalkyl amino, alkylsulfonylimino, alkylsulfinylamino, alkylsulfinylalkyl alkylamino, alkylsulfinylimino, cyano, heterocyclic group, a heterocyclic group of which is a heterocyclic group, a heterocyclic group of which is a heterocyclic group, a heterocyclic group of which is a heterocyclic group, a heterocyclic group of which is a heterocyclic group, a heterocyclic group with a heterocyclic group one or more substituents selected from halogen, alkyl, hydroxy and alkoxy.

Ejemplos de los sustituyentes "alcoxi sustituido o no sustituido", "alcoxicarbonilo sustituido o no sustituido", "alquiltio sustituido o no sustituido", "alquilsulfonilo sustituido o no sustituido" y "alquilsulfinilo sustituido o no sustituido" son uno o más seleccionados del sustituyente grupo α mencionado anteriormente. Examples of the substituents "substituted or unsubstituted alkoxy", "substituted or unsubstituted alkoxycarbonyl", "substituted or unsubstituted alkylthio", "substituted or unsubstituted alkylsulfonyl" and "substituted or unsubstituted alkylsulfinyl" are one or more selected from the substituent α group mentioned above.

Ejemplos de "haloalquilo" son trifluorometilo, fluorometilo y triclorometilo. Examples of "haloalkyl" are trifluoromethyl, fluoromethyl and trichloromethyl.

Ejemplos de "haloalcoxi" son trifluorometoxi, fluorometoxi, triclorometoxi. Examples of "haloalkoxy" are trifluoromethoxy, fluoromethoxy, trichloromethoxy.

El término "alquilideno" incluye un grupo divalente del "alquilo" anterior y ejemplos son metilideno, etilideno, propilideno, isopropilideno, butilideno, pentilideno y hexilideno. The term "alkylidene" includes a divalent group of the above "alkyl" and examples are methylidene, ethylidene, propylidene, isopropylidene, butylidene, pentylidene and hexylidene.

El término "alquenilo" incluye alquenilo lineal o ramificado de un número de carbono de 2 a 15, por ejemplo un número de carbonos de 2 a 10, por ejemplo un número de carbonos de 2 a 6 y, por ejemplo, un número de carbonos de 2 a 4, que tiene uno o más dobles enlaces en cualquier posición disponible. Ejemplos incluyen vinilo, alilo, propenilo, isopropenilo, butenilo, isobutenilo, prenilo, butadienilo, pentenilo, isopentenilo, pentadienilo, hexenilo, isohexenilo, hexadienilo, heptenilo, octenilo, nonenilo, decenilo, undecenilo, dodecenilo, tridecenilo, tetradecenilo y pentadecenilo. The term "alkenyl" includes linear or branched alkenyl of a carbon number from 2 to 15, for example a number of carbons from 2 to 10, for example a number of carbons from 2 to 6 and, for example, a number of carbons 2 to 4, which has one or more double bonds in any available position. Examples include vinyl, allyl, propenyl, isopropenyl, butenyl, isobutenyl, prenyl, butadienyl, pentenyl, isopentenyl, pentadienyl, hexenyl, isohexenyl, hexadienyl, heptenyl, octenyl, nonenyl, decenyl, undecenyl, dodecenyl, tridecenyl and tetradecentayl.

Las porciones alquenilo en "alqueniloxi", "alqueniloxicarbonilo", "carbonilo", "alcoxialquenilloxi", "alquenilsulfonilo" "alquenilamino", "alqueniltio" y "alquenilsulfinilo" son las mismas que el "alquenilo" anterior. The alkenyl portions in "alkenyloxy", "alkenyloxycarbonyl", "carbonyl", "alkoxyalkenyloxy", "alkenylsulfonyl" "alkenylamino", "alkenylthio" and "alkenyl sulfinyl" are the same as the "alkenyl" above.

El término "alquinilo" incluye un alquinilo lineal o ramificado de un número de carbonos de 2 a 10, preferiblemente un número de carbonos de 2 a 8, más preferiblemente un número de carbonos de 3 a 6 que tiene uno o más triples enlaces en las posiciones opcionales. Ejemplos incluyen etinilo, propinilo, butinilo, pentinilo, hexinilo, heptinilo, octinilo, noninilo y decinilo. Estos pueden tener además un doble enlace en cualquier posición disponible. The term "alkynyl" includes a linear or branched alkynyl of a carbon number of 2 to 10, preferably a carbon number of 2 to 8, more preferably a carbon number of 3 to 6 having one or more triple bonds in the optional positions. Examples include ethynyl, propynyl, butynyl, pentinyl, hexinyl, heptinyl, octinyl, noninyl and decinyl. These can also have a double link in any available position.

Porciones alquinilo en "alcoxialquinilo", "alquiniloxi", "alquiniloxicarbonilo", "alquinilcarbonilo", "alcoxialquiniloxi", "alquiniltio", "alquinilsulfinilo", "alquinilsulfonilo" y "alquinilamino" son las mismas que el "alquinilo" anterior. Alkynyl portions in "alkoxyalkynyl", "alkynyloxy", "alkynyloxycarbonyl", "alkynylcarbonyl", "alkoxyalkyloxy", "alkynylthio", "alkylsulfinyl", "alkylsulfonyl" and "alkylamino" are the same as the "alkynyl" above.

14 5 14 5

10 10

15 fifteen

20 twenty

25 25

30 30

35 35

40 40

Ejemplos del sustituyente de "alqueniloxicarbonilo sustituido o no sustituido", "alquenilsulfinilo sustituido o no sustituido", "alquenilo sustituido o no sustituido", "alqueniloxi sustituido o no sustituido", "alqueniltio sustituido o no sustituido", "alquenilsulfonilo sustituido o no sustituido", "alquinilo sustituido o no sustituido", "alquiniloxi sustituido o no sustituido", "alquiniltio sustituido o no sustituido", "alquiniloxicarbonilo sustituido o no sustituido", "alquinilsulfinilo sustituido o no sustituido" y "alquinilsulfonilo sustituido o no sustituido" son uno o más sustituyentes seleccionados del sustituyente grupo α mencionado anteriormente. Examples of the substituent of "substituted or unsubstituted alkenyloxycarbonyl", "substituted or unsubstituted alkenylsulfinyl", "substituted or unsubstituted alkenyl", "substituted or unsubstituted alkenyloxy", "substituted or unsubstituted alkenylthio", "substituted or unsubstituted alkenyl sulfonyl" "," substituted or unsubstituted alkynyl "," substituted or unsubstituted alkynyloxy "," substituted or unsubstituted alkynylthio "," substituted or unsubstituted alkynyloxycarbonyl "," substituted or unsubstituted alkynylsulfinyl "and" substituted or unsubstituted alkynylsulfonyl "are" one or more substituents selected from the group α substituent mentioned above.

Ejemplos del sustituyente en "amino sustituido o no sustituido", "carbamoílo sustituido o no sustituido", "tiocarbamoílo sustituido o no sustituido" y "sulfamoílo sustituido o no sustituido" son uno o dos sustituyentes seleccionados de entre alquilo, acilo, hidroxi, alcoxi, alcoxicarbonilo, grupo carbocíclico y grupo heterocíclico. Examples of the substituent in "substituted or unsubstituted amino", "substituted or unsubstituted carbamoyl", "substituted or unsubstituted thiocarbamoyl" and "substituted or unsubstituted sulfamoyl" are one or two substituents selected from alkyl, acyl, hydroxy, alkoxy , alkoxycarbonyl, carbocyclic group and heterocyclic group.

El término "acilo" incluye formilo, alquilcarbonilo de un número de carbonos de 1 a 10, alquenilcarbonilo de un número de carbonos de 2 a 10, alquinilcarbonilo de un número de carbonos de 2 a 10, carbociclilcarbonilo y heterociclilcarbonilo. Ejemplos son formilo, acetilo, propionilo, butirilo, isobutirilo, valerilo, pivaloilo, hexanoilo, acriloilo, propiolilo, metacriloilo, crotonoilo, benzoilo, ciclohexanocarbonilo, piridincarbonilo, furancarbonilo, tiofencarbonilo, benzotiazolcarbonilo, pirazincarbonilo, piperidincarbonilo y tiomorfolino. The term "acyl" includes formyl, alkylcarbonyl of a number of carbons from 1 to 10, alkenylcarbonyl of a number of carbons from 2 to 10, alkynylcarbonyl of a number of carbons from 2 to 10, carbocyclylcarbonyl and heterocyclylcarbonyl. Examples are formyl, acetyl, propionyl, butyryl, isobutyryl, valeryl, pivaloyl, hexanoyl, acryloyl, propiolilo, methacryloyl, crotonoyl, benzoyl, cyclohexanecarbonyl, pyridinecarbonyl, furancarbonyl, thiophenecarbonyl, benzotiazolcarbonilo, pyrazinecarbonyl, piperidinecarbonyl, and thiomorpholino.

Las porciones de acilo en "aciloxi" y "acilamino" son las mismas que el "acilo" anterior. The acyl portions in "acyloxy" and "acylamino" are the same as the "acyl" above.

Ejemplos de los sustituyentes de "acilo sustituido o no sustituido" y "aciloxi sustituido o no sustituido" son uno o más sustituyentes seleccionados del grupo sustituyente α. Las partes del anillo de carbociclilcarbonilo y heterociclilcarbonilo pueden estar sustituidas con uno o más sustituyentes seleccionados de alquilo, grupo sustituyente α y alquilo sustituido con uno o más sustituyentes seleccionados del grupo sustituyente α. Examples of the "substituted or unsubstituted acyl" and "substituted or unsubstituted acyloxy" substituents are one or more substituents selected from the α substituent group. The parts of the carbocyclylcarbonyl and heterocyclylcarbonyl ring may be substituted with one or more substituents selected from alkyl, substituent group α and alkyl substituted with one or more substituents selected from substituent group α.

La expresión "grupo carbocíclico" incluye cicloalquilo, cicloalquenilo, arilo y carbociclilo condensado no aromático. The term "carbocyclic group" includes cycloalkyl, cycloalkenyl, aryl and non-aromatic condensed carbocyclyl.

El término "cicloalquilo" incluye un grupo carbocíclico de un número de carbonos de 3 a 10, por ejemplo un número de carbonos de 3 a 8 y, por ejemplo, un número de carbonos de 4 a 8. Ejemplos son ciclopropilo, ciclobutilo, ciclopentilo, ciclohexilo, cicloheptilo, ciclooctilo, ciclononilo y ciclodecilo. The term "cycloalkyl" includes a carbocyclic group of a number of carbons from 3 to 10, for example a number of carbons from 3 to 8 and, for example, a number of carbons from 4 to 8. Examples are cyclopropyl, cyclobutyl, cyclopentyl , cyclohexyl, cycloheptyl, cyclooctyl, cyclononyl and cyclodecyl.

Las porciones cicloalquilo en "cicloalquilalquilo", "cicloalquiloxi", "cicloalquilalcoxi", "cicloalquiltio", "cicloalquilamino", "cicloalquilalquilamino", "cicloalquilsulfamoilo", "cicloalquilsulfonilo", "cicloalquilcarbamoílo", "cicloalquilalquilcarbamoílo", "cicloalquilalcoxicarbonilo" y "cicloalquiloxicarbonilo" son las mismas que el "cicloalquilo" anterior. The cycloalkyl portions in "cycloalkylalkyl", "cycloalkyloxy", "cycloalkylalkoxy", "cycloalkylthio", "cycloalkylamino", "cycloalkylalkylamino" "cicloalquilsulfamoilo", "cycloalkylsulfonyl", "cycloalkylcarbamoyl", "cicloalquilalquilcarbamoílo" "cycloalkylalkoxycarbonyl" and "cycloalkyloxycarbonyl "are the same as the" cycloalkyl "above.

El término "cicloalquenilo" incluye un grupo que tiene uno o más dobles enlaces en las posiciones opcionalmente en el anillo de "cicloalquilo" anterior. Ejemplos son ciclopropenilo, ciclobutenilo, ciclopentenilo, ciclohexenilo, cicloheptenilo, ciclooctenilo y ciclohexadienilo. The term "cycloalkenyl" includes a group having one or more double bonds at the positions optionally in the "cycloalkyl" ring above. Examples are cyclopropenyl, cyclobutenyl, cyclopentenyl, cyclohexenyl, cycloheptenyl, cyclooctenyl and cyclohexadienyl.

El término "arilo" incluye fenilo, naftilo, antrilo y fenantrilo. Un ejemplo específico es fenilo. The term "aryl" includes phenyl, naphthyl, antryl and phenanthryl. A specific example is phenyl.

La expresión "grupo carbocíclico condensado no aromático" incluye grupos no aromáticos en los que dos o más grupos cíclicos seleccionados de los anteriores "cicloalquilo", "cicloalquenilo" y "arilo" están condensados. Ejemplos son indanilo, indenilo, tetrahidronaftilo y fluorenilo. The term "non-aromatic condensed carbocyclic group" includes non-aromatic groups in which two or more cyclic groups selected from the above "cycloalkyl", "cycloalkenyl" and "aryl" are condensed. Examples are indanyl, indenyl, tetrahydronaphthyl and fluorenyl.

Las porciones carbociclo en "carbociclo no aromático" son las mismas que "cicloalquilo", "cicloalquenilo" y "grupo carbocíclico no aromático condensado". Ejemplos son ciclopropano, ciclobutano, ciclopentano, ciclohexano, cicloheptano, ciclooctano, ciclononano, ciclodecano, ciclopropeno, ciclobuteno, ciclopenteno, ciclohexeno, ciclohepteno y cicloocteno. The carbocycle portions in "non-aromatic carbocycle" are the same as "cycloalkyl", "cycloalkenyl" and "condensed non-aromatic carbocyclic group". Examples are cyclopropane, cyclobutane, cyclopentane, cyclohexane, cycloheptane, cyclooctane, cyclononane, cyclodecane, cyclopropene, cyclobutene, cyclopentene, cyclohexene, cycloheptene and cyclooctene.

Las porciones carbociclo en "carbociclo", "carbocicliloxi", "carbociclilalquilo", "carbociclilalcoxi", "carbociclilalcoxicarbonilo", "carbocicliltio", "carbociclilamino", "carbociclilalquilamino", "carbociclilcarbonilo", "carbociclilsulfamoílo", "carbociclilsulfonilo", "carbociclilcarbamoílo", "carbociclilalquilcarbamoílo", "carbocicliloxicarbonilo", "carbociclilsulfinilo" y "carbociclilsulfonilo" son las mismas que las del "grupo carbocíclico" anterior. The carbocycle portions in "carbocycle", "carbocyclyloxy", "carbocyclylalkyl", "carbocyclylalkoxy", "carbocyclylalkoxycarbonyl", "carbocyclylthio", "carbocyclylamino", "carbocyclyl-alkylamino", "carbocyclylcarbonyloxycarbonylalkylcarbonylalkylcarbonylalkylcarbonylalkylcarbonylalkylcarbonylalkylcarbonylalkyl" "," carbocyclyl alkylcarbamoyl "," carbocyclyloxycarbonyl "," carbocyclylsulfinyl "and" carbocyclylsulfonyl "are the same as those of the" carbocyclic group "above.

15 fifteen

imagen13image13

imagen14image14

en el que el anillo A' y el anillo B son, cada uno independientemente, carbociclo sustituido o heterociclo sustituido o no sustituido, L1, L2 y L3 son, cada uno independientemente, un enlace, alquileno sustituido o no sustituido, alquenileno sustituido wherein the A 'ring and the B ring are each independently substituted or unsubstituted carbocycle or L1, L2 and L3 are each independently a bond, substituted or unsubstituted alkylene, substituted alkenylene

5 o no sustituido o alquinileno sustituido o no sustituido, =W1 es =O, =S o =NR9, W2es O, S o N(R5), R8 es hidrógeno, alquilo sustituido o no sustituido, alquenilo sustituido o no sustituido, alquinilo sustituido o no sustituido o acilo sustituido o no sustituido, R9 es hidrógeno, hidroxi, alquilo sustituido o no sustituido, alquenilo sustituido o no sustituido, alquinilo sustituido o 5 or unsubstituted or substituted or unsubstituted alkynylene, = W1 is = O, = S or = NR9, W2 is O, S or N (R5), R8 is hydrogen, substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl, alkynyl substituted or unsubstituted or substituted or unsubstituted acyl, R9 is hydrogen, hydroxy, substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl, substituted alkynyl or

10 no sustituido o acilo sustituido o no sustituido, cuando el anillo A es (i), entonces el átomo de carbono constituyente de L1 y el átomo de carbono constituyente de L2, o el átomo de carbono constituyente de L1 y el átomo de nitrógeno de W2 pueden estar conectados con alquileno sustituido o no sustituido para formar un anillo, cuando el anillo A es (ii), entonces el átomo de carbono constituyente de L1 y el átomo de carbono constituyente de 10 unsubstituted or substituted or unsubstituted acyl, when ring A is (i), then the constituent carbon atom of L1 and the constituent carbon atom of L2, or the constituent carbon atom of L1 and the nitrogen atom of W2 may be connected with substituted or unsubstituted alkylene to form a ring, when ring A is (ii), then the constituent carbon atom of L1 and the constituent carbon atom of

15 L2, o el átomo de nitrógeno de W2 y el átomo de carbono constituyente de L2 pueden estar conectados con alquileno sustituido o no sustituido para formar un anillo, cuando el anillo A es (iii), entonces dos átomos de nitrógeno de W2 pueden estar conectados con alquileno sustituido 15 L2, or the nitrogen atom of W2 and the carbon atom constituting L2 can be connected with substituted or unsubstituted alkylene to form a ring, when the ring A is (iii), then two nitrogen atoms of W2 can be connected with substituted alkylene

o no sustituido para formar un anillo, cuando el anillo A es (vi), entonces el átomo de carbono constituyente de L1 y el átomo de carbono constituyente de or unsubstituted to form a ring, when ring A is (vi), then the carbon atom constituting L1 and the carbon atom constituting

20 L2 pueden estar conectados por alquileno sustituido o no sustituido para formar un anillo, p es 1 o 2, y cuando están presentes múltiples L3, múltiples W2 o múltiples R9, cada uno de ellos puede ser independientemente diferente. Ejemplos específicos son los siguientes: 20 L2 may be connected by substituted or unsubstituted alkylene to form a ring, p is 1 or 2, and when multiple L3, multiple W2 or multiple R9 are present, each of them can be independently different. Specific examples are as follows:

25 [Fórmula Química 23] 25 [Chemical Formula 23]

17 17

imagen15image15

[Fórmula Química 24] [Chemical Formula 24]

18 18

imagen16image16

en la que L es, cada uno independientemente, un enlace, alquileno sustituido o no sustituido, alquenileno sustituido o no sustituido o alquinileno sustituido o no sustituido, el anillo T es un carbociclo opcionalmente sustituido con un o unos grupos seleccionados del grupo sustituyente α, o un heterociclo opcionalmente sustituido con un o unos grupos seleccionados del grupo α, y esos y otros símbolos son los mismos que se han definido anteriormente. wherein L is each independently a bond, substituted or unsubstituted alkylene, substituted or unsubstituted alkenylene or substituted or unsubstituted alkynylene, the T-ring is a carbocycle optionally substituted with one or a few groups selected from the substituent group α, or a heterocycle optionally substituted with one or a few groups selected from the α group, and those and other symbols are the same as defined above.

Ejemplos más específicos son los siguientes: More specific examples are the following:

[Fórmula Química 25] [Chemical Formula 25]

19 19

imagen17image17

en la que cada uno de los símbolos es como se ha definido anteriormente. [Fórmula Química 26] in which each of the symbols is as defined above. [Chemical Formula 26]

20 twenty

imagen18image18

en la que cada uno de los símbolos es como se ha definido anteriormente. in which each of the symbols is as defined above.

Otros ejemplos del sustituyente de "carbociclo sustituido", "carbociclo sustituido o no sustituido", "heterociclo Other examples of the substituent of "substituted carbocycle", "substituted or unsubstituted carbocycle", "heterocycle

5 sustituido o no sustituido", "benceno sustituido o no sustituido", "piridina sustituida o no sustituida", "pirimidina sustituida o no sustituida" y "pirazina sustituida o no sustituida" en el anillo A, el anillo A' y el anillo B incluyen: un grupo seleccionado del grupo sustituyente α tal como halógeno, hidroxi, alcoxi, acilo, aciloxi, carboxi, alcoxicarbonilo, carbamoilo, amino, ciano, alquilamino y/o alquiltio; alquilo sustituido con uno o más grupos seleccionados del grupo sustituyente α, hidroxiimino y alcoxiimino, en el que 5 substituted or unsubstituted "," substituted or unsubstituted benzene "," substituted or unsubstituted pyridine "," substituted or unsubstituted pyrimidine "and" substituted or unsubstituted pyrazine "in ring A, ring A 'and ring B include: a group selected from the substituent group α such as halogen, hydroxy, alkoxy, acyl, acyloxy, carboxy, alkoxycarbonyl, carbamoyl, amino, cyano, alkylamino and / or alkylthio; alkyl substituted with one or more groups selected from the substituent group α , hydroxyimino and alkoxyimino, in which

10 el sustituyente es, por ejemplo, halógeno, hidroxi, alcoxi y/o alcoxicarbonilo, o alquilo no sustituido; aminoalquilo sustituido con uno o más grupos seleccionados del grupo sustituyente α; en el que el sustituyente es, por ejemplo, acilo, alquilo y/o alcoxi; alquenilo sustituido con uno o más sustituyentes seleccionados del grupo sustituyente α, en el que el sustituyente es, por ejemplo, alcoxicarbonilo, halógeno y/o halogenoalcoxicarbonilo, o alquenilo no sustituido; The substituent is, for example, halogen, hydroxy, alkoxy and / or alkoxycarbonyl, or unsubstituted alkyl; aminoalkyl substituted with one or more groups selected from the α substituent group; wherein the substituent is, for example, acyl, alkyl and / or alkoxy; alkenyl substituted with one or more substituents selected from the α substituent group, wherein the substituent is, for example, alkoxycarbonyl, halogen and / or halogenoalkoxycarbonyl, or unsubstituted alkenyl;

15 alquinilo sustituido con uno o más sustituyentes seleccionados del grupo sustituyente α, en el que el sustituyente es, por ejemplo, alcoxicarbonilo o alquinilo no sustituido; alcoxi sustituido con uno o más sustituyentes seleccionados del Alkynyl substituted with one or more substituents selected from the substituent group α, in which the substituent is, for example, alkoxycarbonyl or unsubstituted alkynyl; alkoxy substituted with one or more substituents selected from the

21 5 21 5

10 10

15 fifteen

20 twenty

25 25

30 30

35 35

40 40

45 Four. Five

50 fifty

55 55

60 60

grupo sustituyente α, en el que el sustituyente es, por ejemplo, halógeno, carbamoilo, alquilcarbamoilo y/o hidroxialquilcarbamoílo; alcoxialcoxi sustituido con uno o más sustituyentes seleccionados del grupo sustituyente α; alqueniloxi sustituido con uno o más sustituyentes seleccionados del grupo sustituyente α, en el que el sustituyente es, por ejemplo, halógeno, hidroxi, amino y/o alquilamino, o alqueniloxi no sustituido; alcoxialquenilloxi sustituido con uno o más sustituyentes seleccionados del grupo sustituyente α; alquiniloxi sustituido con uno o más sustituyentes seleccionados del grupo sustituyente α, en el que el sustituyente es, por ejemplo, halógeno y/o hidroxi o alquiniloxi no sustituido; alcoxialquiniloxi sustituido con uno o más grupos seleccionados del grupo sustituyente α; alquiltio sustituido con uno o más sustituyentes seleccionados del grupo sustituyente α, o alquiltio sustituido; alqueniltio sustituido con uno o más sustituyentes seleccionados del grupo sustituyente α, o alqueniltio no sustituido; alquiniltio sustituido con uno o más sustituyentes seleccionados del grupo sustituyente α, o alquiniltio no sustituido; alquilamino sustituido con uno o más sustituyentes seleccionados del grupo sustituyente α; alquenilamino sustituido con uno o más sustituyentes seleccionados del grupo sustituyente α; alquinilamino sustituido con uno o más sustituyentes seleccionados del grupo sustituyente α; aminooxi sustituido con uno o más sustituyentes seleccionados del grupo sustituyente α y alquilideno, o aminooxi no sustituido; acilo sustituido con uno o más sustituyentes seleccionados entre el grupo sustituyente α; alquilsulfonilo sustituido con uno o más sustituyentes seleccionados del grupo sustituyente α, o alquilsulfonilo sustituido; alquilsulfinilo sustituido con uno o más sustituyentes seleccionados del grupo sustituyente α, o alquilsulfinilo no sustituido; alquilsulfamoilo sustituido con uno o más sustituyentes seleccionados del grupo sustituyente α; un grupo carbocíclico tal como cicloalquilo y arilo, sustituido con uno o más sustituyentes seleccionados del grupo sustituyente α, azida, alquilo y haloalquilo; un grupo heterocíclico sustituido con uno o más sustituyentes seleccionados del grupo sustituyente α, azida, alquilo y haloalquilo; carbociclilalquilo tal como cicloalquilalquilo y arilalquilo, sustituido con uno o más sustituyentes seleccionados del grupo sustituyente α, azida, alquilo y haloalquilo, o carbociclilalquilo no sustituido; heterociclilalquilo sustituido con uno o más sustituyentes seleccionados del grupo sustituyente α, azida, alquilo y haloalquilo, o heterociclilalquilo sustituido; carbocicliloxi como cicloalquiloxi y ariloxi, sustituido con uno o más sustituyentes seleccionados del grupo sustituyente α, azida, alquilo y haloalquilo, o carbocicliloxi no sustituido; heterocicliloxi sustituido con uno o más sustituyentes seleccionados del grupo sustituyente α, azida, alquilo y haloalquilo, o heterocicliloxi no sustituido; carbociclilalcoxi tal como cicloalquilalcoxi y arilalcoxi, sustituido con uno o más sustituyentes seleccionados del grupo sustituyente α, azida, alquilo y haloalquilo, o carbociclilalcoxi no sustituido; heterociclilalcoxi sustituido con uno o más sustituyentes seleccionados del grupo sustituyente α, azida, alquilo y haloalquilo, o heterociclilalcoxi no sustituido; carbociclilalcoxicarbonilo tal como cicloalquilalcoxicarbonilo y arilalcoxicarbonilo, sustituido con uno o más sustituyentes seleccionados del grupo sustituyente α, azida, alquilo y haloalquilo, o carbociclilalcoxicarbonilo no sustituido tal como cicloalquilalcoxicarbonilo y arilalcoxicarbonilo; heterociclilalcoxicarbonilo sustituido con uno o más sustituyentes seleccionados del grupo sustituyente α, azida, alquilo y haloalquilo, o heterociclilalcoxicarbonilo no sustituido; carbocicliltio tal como cicloalquiltio y ariltio, sustituido con uno o más sustituyentes seleccionados del grupo sustituyente α, azida, alquilo y haloalquilo, o carbocicliltio no sustituido tal como cicloalquiltio y ariltio; heterocicliltio sustituido con uno o más sustituyentes seleccionados del grupo sustituyente α, azida, alquilo y haloalquilo, o heterocicliltio no sustituido; carbociclilamino tal como cicloalquilamino y arilamino, sustituido con uno o más sustituyentes seleccionados del grupo sustituyente α, azida, alquilo y haloalquilo, o carbociclilamino no sustituido tal como cicloalquilamino y arilamino; heterociclilamino sustituido con uno o más sustituyentes seleccionados del grupo sustituyente α, azida, alquilo y haloalquilo, o heterociclilamino no sustituido; carbociclilalquilamino tal como cicloalquilalquilamino y arilalquilamino, sustituido con uno o más sustituyentes seleccionados del grupo sustituyente α, azida, alquilo y haloalquilo o carbociclilalquilamino no sustituido tal como cicloalquilalquilamino y arilalquilamino; heterociclilalquilamino sustituido con uno o más sustituyentes seleccionados del grupo sustituyente α, azida, alquilo y haloalquilo, o heterociclilalquilamino no sustituido; carbociclilsulfamoílo tal como cicloalquilsulfamoílo y arilsulfamoílo, sustituido con uno o más sustituyentes seleccionados del grupo sustituyente α, azida, alquilo y haloalquilo, o carbociclilsulfamoílo no sustituido; heterociclilsulfamoílo sustituido con uno o más sustituyentes seleccionados del grupo sustituyente α, azida, alquilo y haloalquilo, o heterociclilsulfamoílo no sustituido; α substituent group, in which the substituent is, for example, halogen, carbamoyl, alkylcarbamoyl and / or hydroxyalkylcarbamoyl; alkoxyalkoxy substituted with one or more substituents selected from the α substituent group; alkenyloxy substituted with one or more substituents selected from the α substituent group, wherein the substituent is, for example, halogen, hydroxy, amino and / or alkylamino, or unsubstituted alkenyloxy; alkoxyalkenyloxy substituted with one or more substituents selected from the α substituent group; alkynyloxy substituted with one or more substituents selected from the substituent group α, wherein the substituent is, for example, halogen and / or hydroxy or unsubstituted alkynyloxy; alkoxyalkyloxy substituted with one or more groups selected from the α substituent group; alkylthio substituted with one or more substituents selected from the substituent group α, or substituted alkylthio; alkenylthio substituted with one or more substituents selected from the substituent group α, or unsubstituted alkenylthio; alkynylthio substituted with one or more substituents selected from the substituent group α, or unsubstituted alkynylthio; alkylamino substituted with one or more substituents selected from the substituent group α; alkenylamino substituted with one or more substituents selected from the α substituent group; alkylamino substituted with one or more substituents selected from the α substituent group; aminooxy substituted with one or more substituents selected from the substituent group α and alkylidene, or unsubstituted aminooxy; acyl substituted with one or more substituents selected from the substituent group α; alkylsulfonyl substituted with one or more substituents selected from the substituent group α, or substituted alkylsulfonyl; alkylsulfinyl substituted with one or more substituents selected from the substituent group α, or unsubstituted alkylsulfinyl; alkylsulfamoyl substituted with one or more substituents selected from the α substituent group; a carbocyclic group such as cycloalkyl and aryl, substituted with one or more substituents selected from the substituent group α, azide, alkyl and haloalkyl; a heterocyclic group substituted with one or more substituents selected from the substituent group α, azide, alkyl and haloalkyl; carbocyclylalkyl such as cycloalkylalkyl and arylalkyl, substituted with one or more substituents selected from the substituent group α, azide, alkyl and haloalkyl, or unsubstituted carbocyclylalkyl; heterocyclylalkyl substituted with one or more substituents selected from the substituent group α, azide, alkyl and haloalkyl, or substituted heterocyclylalkyl; carbocyclyloxy such as cycloalkyloxy and aryloxy, substituted with one or more substituents selected from the substituent group α, azide, alkyl and haloalkyl, or unsubstituted carbocyclyloxy; heterocyclyloxy substituted with one or more substituents selected from the substituent group α, azide, alkyl and haloalkyl, or unsubstituted heterocyclyloxy; carbocyclylalkoxy such as cycloalkylalkoxy and arylalkoxy, substituted with one or more substituents selected from the substituent group α, azide, alkyl and haloalkyl, or unsubstituted carbocyclylalkoxy; heterocyclylalkoxy substituted with one or more substituents selected from the substituent group α, azide, alkyl and haloalkyl, or unsubstituted heterocyclylalkoxy; carbocyclylalkoxycarbonyl such as cycloalkylalkoxycarbonyl and arylalkoxycarbonyl, substituted with one or more substituents selected from the substituent group α, azide, alkyl and haloalkyl, or unsubstituted carbocyclylalkoxycarbonyl such as cycloalkylalkoxycarbonyl and arylalkoxycarbonyl; heterocyclylalkoxycarbonyl substituted with one or more substituents selected from the substituent group α, azide, alkyl and haloalkyl, or unsubstituted heterocyclylalkoxycarbonyl; carbocyclylthio such as cycloalkylthio and arylthio, substituted with one or more substituents selected from the substituent group α, azide, alkyl and haloalkyl, or unsubstituted carbocyclylthio such as cycloalkylthio and arylthio; heterocyclyl substituted with one or more substituents selected from the substituent group α, azide, alkyl and haloalkyl, or unsubstituted heterocyclyl; carbocyclylamino such as cycloalkylamino and arylamino, substituted with one or more substituents selected from the substituent group α, azide, alkyl and haloalkyl, or unsubstituted carbocyclylamino such as cycloalkylamino and arylamino; heterocyclylamino substituted with one or more substituents selected from the substituent group α, azide, alkyl and haloalkyl, or unsubstituted heterocyclylamino; carbocyclylalkylamino such as cycloalkylalkylamino and arylalkylamino, substituted with one or more substituents selected from the substituent group α, azide, alkyl and haloalkyl or unsubstituted carbocyclylalkylamino such as cycloalkylalkylamino and arylalkylamino; heterocyclylalkylamino substituted with one or more substituents selected from the substituent group α, azide, alkyl and haloalkyl, or unsubstituted heterocyclylalkylamino; carbocyclylsulfamoyl such as cycloalkylsulfamoyl and arylsulfamoyl, substituted with one or more substituents selected from the substituent group α, azide, alkyl and haloalkyl, or unsubstituted carbocyclylsulfamoyl; heterocyclylsulfamoyl substituted with one or more substituents selected from the substituent group α, azide, alkyl and haloalkyl, or unsubstituted heterocyclylsulfamoyl;

22 22

carbociclilsulfonilo tal como cicloalquilsulfonilo y arilsulfonilo, sustituido con uno o más sustituyentes seleccionados del grupo sustituyente α, azida, alquilo y haloalquilo, o carbociclilsulfonilo no sustituido tal como cicloalquilsulfonilo y arilsulfonilo; heterociclilsulfonilo sustituido con uno o más sustituyentes seleccionados del grupo sustituyente α, azida, alquilo y carbocyclylsulfonyl such as cycloalkylsulfonyl and arylsulfonyl, substituted with one or more substituents selected from the substituent group α, azide, alkyl and haloalkyl, or unsubstituted carbocyclylsulfonyl such as cycloalkylsulfonyl and arylsulfonyl; heterocyclylsulfonyl substituted with one or more substituents selected from the substituent group α, azide, alkyl and

5 haloalquilo, o heterociclilsulfonilo no sustituido; carbociclilcarbamoílo tal como cicloalquilcarbamoílo y arilcarbamoilo, sustituido con uno o más sustituyentes seleccionados del grupo sustituyente α, azida, alquilo y haloalquilo, o carbociclilcarbamoílo no sustituido tal como cicloalquilcarbamoílo y arilcarbamoilo; heterociclilcarbamoílo sustituido con uno o más sustituyentes seleccionados del grupo sustituyente α, azida, alquilo y Haloalkyl, or unsubstituted heterocyclylsulfonyl; carbocyclylcarbamoyl such as cycloalkylcarbamoyl and arylcarbamoyl, substituted with one or more substituents selected from the substituent group α, azide, alkyl and haloalkyl, or unsubstituted carbocyclylcarbamoyl such as cycloalkylcarbamoyl and arylcarbamoyl; heterocyclylcarbamoyl substituted with one or more substituents selected from the substituent group α, azide, alkyl and

10 haloalquilo, o heterociclilcarbamoílo no sustituido; carbociclilalquilcarbamoílo tal como cicloalquilalquilcarbamoílo y arilalquilcarbamoílo, sustituido con uno o más sustituyentes seleccionados del grupo sustituyente α, azida, alquilo y haloalquilo, o carbociclilalquilcarbamoílo no sustituido tal como cicloalquilalquilcarbamoílo y arilalquilcarbamoílo; heterociclilalquilcarbamoílo sustituido con uno o más sustituyentes seleccionados del grupo sustituyente α, azida, Haloalkyl, or unsubstituted heterocyclylcarbamoyl; carbocyclyl alkylcarbamoyl such as cycloalkylalkylcarbamoyl and arylalkylcarbamoyl, substituted with one or more substituents selected from the substituent group α, azide, alkyl and haloalkyl, or unsubstituted carbocyclyl alkylcarbamoyl such as cycloalkylalkylcarbamoyl and arylalkylcarbamoyl; heterocyclyl alkylcarbamoyl substituted with one or more substituents selected from the substituent group α, azide,

15 alquilo y haloalquilo, o heterociclilalquilcarbamoílo no sustituido; carbocicliloxicarbonilo tal como cicloalquiloxicarbonilo y ariloxicarbonilo, sustituido con uno o más sustituyentes seleccionados del grupo sustituyente α, azida, alquilo y haloalquilo, o carbocicliloxicarbonilo no sustituido tal como cicloalquiloxicarbonilo y ariloxicarbonilo; heterocicliloxicarbonilo sustituido con uno o más sustituyentes seleccionados del grupo sustituyente α, azida, alquilo Alkyl and haloalkyl, or unsubstituted heterocyclyl alkylcarbamoyl; carbocyclyloxycarbonyl such as cycloalkyloxycarbonyl and aryloxycarbonyl, substituted with one or more substituents selected from the substituent group α, azide, alkyl and haloalkyl, or unsubstituted carbocyclyloxycarbonyl such as cycloalkyloxycarbonyl and aryloxycarbonyl; heterocyclyloxycarbonyl substituted with one or more substituents selected from the substituent group α, azide, alkyl

20 y haloalquilo, o heterocicliloxicarbonilo no sustituido; alquilendioxi sustituido con halógeno, o alquilendioxi no sustituido; oxo; y azida. 20 and haloalkyl, or unsubstituted heterocyclyloxycarbonyl; halogen substituted alkylenedioxy, or unsubstituted alkylenedioxy; oxo; and azide.

El anillo antes mencionado del anillo A y el anillo B cada uno puede estar sustituido con uno o más sustituyentes 25 seleccionados de entre ellos. The aforementioned ring of ring A and ring B each may be substituted with one or more substituents selected from each other.

En la memoria descriptiva, ejemplos del sustituyente de "carbociclo no sustituido", "benceno sustituido o no sustituido", "heterociclo sustituido o no sustituido", "piridina sustituida o no sustituida", "pirimidina sustituida o no sustituida" y "pirazina sustituida o no sustituida" en el anillo A' y el anillo B incluyen halógeno, ciano, hidroxi, nitro, carboxi, alquilo sustituido con uno o más sustituyentes seleccionados del grupo sustituyente α, alquilo no sustituido, In the specification, examples of the substituent of "unsubstituted carbocycle", "substituted or unsubstituted benzene", "substituted or unsubstituted heterocycle", "substituted or unsubstituted pyridine", "substituted or unsubstituted pyrimidine" and "substituted pyrazine or unsubstituted "in ring A 'and ring B include halogen, cyano, hydroxy, nitro, carboxy, alkyl substituted with one or more substituents selected from the substituent group α, unsubstituted alkyl,

30 alcoxi sustituido con uno o más sustituyentes seleccionados del grupo sustituyente α, alcoxi no sustituido, amino sustituido con uno o más sustituyentes seleccionados del grupo sustituyente α, amino no sustituido, carbamoílo sustituido con uno o más sustituyentes seleccionados del grupo sustituyente α, carbamoílo no sustituido, alcoxicarbonilo sustituido con uno o más sustituyentes seleccionados del grupo sustituyente α, y alcoxicarbonilo no sustituido. 30 alkoxy substituted with one or more substituents selected from the substituent group α, unsubstituted alkoxy, amino substituted with one or more substituents selected from the substituent group α, unsubstituted amino, carbamoyl substituted with one or more substituents selected from the substituent group α, carbamoyl substituted, alkoxycarbonyl substituted with one or more substituents selected from the substituent group α, and unsubstituted alkoxycarbonyl.

35 Ejemplos de los sustituyentes que no sean "Z-anillo B" de "carbociclo sustituido o no sustituido" o "heterociclo sustituido o no sustituido" en el anillo A incluyen halógeno, alquilo, alquenilo, alquinilo, alcoxi, alqueniloxi, alquiniloxi Examples of substituents other than "Z-ring B" of "substituted or unsubstituted carbocycle" or "substituted or unsubstituted heterocycle" in ring A include halogen, alkyl, alkenyl, alkynyl, alkoxy, alkenyloxy, alkynyloxy

o ciano. or cyano.

Ejemplos de los sustituyentes de "carbociclo sustituido o no sustituido", "benceno sustituido o no sustituido" o "heterociclo sustituido o no sustituido" en el anillo A' incluyen halógeno. Examples of the substituents of "substituted or unsubstituted carbocycle," "substituted or unsubstituted benzene" or "substituted or unsubstituted heterocycle" on the A 'ring include halogen.

40 Ejemplos de los sustituyentes de "carbociclo sustituido o no sustituido", "heterociclo sustituido o no sustituido", "piridina sustituida o no sustituida", "pirimidina sustituida o no sustituida" o "pirazina sustituida o no sustituida" en el anillo B incluyen halógeno, alquilo, alquenilo, alquinilo, alcoxi, alqueniloxi, alquiniloxi o ciano. Examples of the substituents of "substituted or unsubstituted carbocycle", "substituted or unsubstituted heterocycle", "substituted or unsubstituted pyridine", "substituted or unsubstituted pyrimidine" or "substituted or unsubstituted pyrazine" in ring B include halogen, alkyl, alkenyl, alkynyl, alkoxy, alkenyloxy, alkynyloxy or cyano.

Ejemplos de los sustituyentes de "grupo carbocíclico sustituido o no sustituido", "carbocicliltio sustituido o no sustituido", "carbocicliloxicarbonilo sustituido o no sustituido", "heterociclilo sustituido o no sustituido", "carbocicliloxi 45 sustituido o no sustituido", "carbociclilsulfinilo sustituido o no sustituido", "carbaciclilsulfonilo sustituido o no sustituido", "carbociclo sustituido o no sustituido", "heterociclilo sustituido o no sustituido", "heterocicliloxi sustituido o no sustituido", "heterocicliltio sustituido o no sustituido", "heterocicliloxicarbonilo sustituido o no sustituido", "heterociclilsulfinilo sustituido o no sustituido", "heterociclilsulfonilo sustituido o no sustituido", "heterociclo sustituido Examples of the substituents of "substituted or unsubstituted carbocyclic group", "substituted or unsubstituted carbocyclylthio", "substituted or unsubstituted carbocyclyloxycarbonyl", "substituted or unsubstituted heterocyclyl", "substituted or unsubstituted carbocyclyloxy", "carbocyclylsulfinyl substituted or unsubstituted "," substituted or unsubstituted carbacyclylsulfonyl "," substituted or unsubstituted carbocycle "," substituted or unsubstituted heterocyclyl "," substituted or unsubstituted heterocyclyloxy "," substituted or unsubstituted heterocyclylthioxy " substituted "," substituted or unsubstituted heterocyclylsulfinyl "," substituted or unsubstituted heterocyclylsulfonyl "," substituted heterocycle

o no sustituido", " ciclopentano sustituido o no sustituido", "ciclopenteno sustituido o no sustituido", "ciclohexano or unsubstituted "," substituted or unsubstituted cyclopentane "," substituted or unsubstituted cyclopentene "," cyclohexane

50 sustituido o no sustituido" y "ciclohexeno sustituido o no sustituido" en otro distinto de anillo A., anillo A' y anillo B anteriores incluyen uno o más sustituyentes seleccionados del grupo sustituyente α, alquilo no sustituido y alquilo sustituido con uno o más sustituyentes seleccionados del grupo sustituyente α. "Substituted or unsubstituted" and "substituted or unsubstituted cyclohexene" in another other than ring A., ring A 'and ring B above include one or more substituents selected from the substituent group α, unsubstituted alkyl and alkyl substituted with one or more substituents selected from the substituent group α.

23 2. 3

imagen19image19

imagen20image20

[Formula Química 29] [Chemical Formula 29]

25 25

imagen21image21

[Formula Química 30] [Chemical Formula 30]

26 26

imagen22image22

Estos grupos pueden estar sustituidos con uno o más seleccionados de entre alquilo sustituido con uno o más seleccionados del grupo sustituyente α, alquilo no sustituido y alquilo sustituido con uno o más sustituyentes seleccionados del grupo sustituyente α en cualquier posición disponible. These groups may be substituted with one or more selected from alkyl substituted with one or more selected from the substituent group α, unsubstituted alkyl and alkyl substituted with one or more substituents selected from the substituent group α at any available position.

Ejemplos de grupos en los que Examples of groups in which

[Formula Química 31] [Chemical Formula 31]

imagen23image23

en la que cada símbolo es como se ha definido en el apartado (1), y Q' es carbociclo sustituido o no sustituido, incluyen [Formula Química 32] in which each symbol is as defined in section (1), and Q 'is substituted or unsubstituted carbocycle, include [Chemical Formula 32]

imagen24image24

Estos grupos pueden estar sustituidos con uno o más seleccionados de entre alquilo sustituido con uno o más seleccionados del grupo sustituyente α, alquilo no sustituido y alquilo sustituido con uno o más sustituyentes seleccionados del grupo sustituyente α en cualquier posición disponible. These groups may be substituted with one or more selected from alkyl substituted with one or more selected from the substituent group α, unsubstituted alkyl and alkyl substituted with one or more substituents selected from the substituent group α at any available position.

La frase "Rza y Rzb, junto con el átomo de carbono al que están unidos, pueden formar un carbociclo no aromático 15 sustituido o no sustituido o un heterociclo no aromático sustituido o no sustituido" incluyen los siguientes ejemplos. The phrase "Rza and Rzb, together with the carbon atom to which they are attached, can form a substituted or unsubstituted non-aromatic carbocycle or a substituted or unsubstituted non-aromatic heterocycle" include the following examples.

[Formula Química 33] [Chemical Formula 33]

28 28

imagen25image25

imagen26image26

Estos grupos pueden estar sustituidos con uno o más seleccionados de entre alquilo sustituido con uno o más seleccionados del grupo sustituyente α, alquilo no sustituido y alquilo sustituido con uno o más sustituyentes seleccionados del grupo sustituyente α en cualquier posición disponible. These groups may be substituted with one or more selected from alkyl substituted with one or more selected from the substituent group α, unsubstituted alkyl and alkyl substituted with one or more substituents selected from the substituent group α at any available position.

5 En la memoria descriptiva, el término "solvato" incluye, por ejemplo, solvatos con disolventes orgánicos e hidratos. Se puede preparar de acuerdo con los métodos conocidos. Ejemplos de solvato incluyen un solvato con acetona, 2butanol, 2-propanol, etanol, acetato de etilo, tetrahidrofurano o dietiléter. Por ejemplo, incluye un hidrato no tóxico y soluble en agua o un solvato tal como un solvato con etanol. En el caso que se forma un hidrato o solvato, el compuesto o la sal pueden coordinarse con cualquier número de moléculas de solvato o moléculas de agua. 5 In the specification, the term "solvate" includes, for example, solvates with organic solvents and hydrates. It can be prepared according to known methods. Examples of solvate include a solvate with acetone, 2butanol, 2-propanol, ethanol, ethyl acetate, tetrahydrofuran or diethyl ether. For example, it includes a non-toxic and water-soluble hydrate or a solvate such as a solvate with ethanol. In the case that a hydrate or solvate is formed, the compound or salt can be coordinated with any number of solvate molecules or water molecules.

10 El compuesto de la fórmula (I) incluye una sal farmacéuticamente aceptable. Ejemplos incluyen sales con metales alcalinos tales como litio, sodio o potasio; metales alcalinotérreos tales como calcio; magnesio; metales de transición tales como zinc o hierro; amonio; bases orgánicas; y aminoácidos; o sales con ácidos inorgánicos tales como ácido clorhídrico, ácido sulfúrico, ácido nítrico, ácido bromhídrico, ácido fosfórico o ácido yodhídrico; y ácidos orgánicos tales como ácido acético, ácido trifluoroacético, ácido cítrico, ácido láctico, ácido tartárico, ácido oxálico, ácido The compound of the formula (I) includes a pharmaceutically acceptable salt. Examples include salts with alkali metals such as lithium, sodium or potassium; alkaline earth metals such as calcium; magnesium; transition metals such as zinc or iron; ammonium; organic bases; and amino acids; or salts with inorganic acids such as hydrochloric acid, sulfuric acid, nitric acid, hydrobromic acid, phosphoric acid or hydroiodic acid; and organic acids such as acetic acid, trifluoroacetic acid, citric acid, lactic acid, tartaric acid, oxalic acid, acid

15 maleico, ácido fumárico, ácido mandélico, ácido glutárico, ácido málico, ácido benzoico, ácido ftálico, ácido bencenosulfónico, ácido p-toluenosulfónico, ácido metanosulfónico o ácido etanosulfónico. Ejemplos específicos son ácido clorhídrico, ácido fosfórico, ácido tartárico y ácido metanosulfónico. Estas sales se pueden formar por métodos ordinarios. Maleic, fumaric acid, mandelic acid, glutaric acid, malic acid, benzoic acid, phthalic acid, benzenesulfonic acid, p-toluenesulfonic acid, methanesulfonic acid or ethanesulfonic acid. Specific examples are hydrochloric acid, phosphoric acid, tartaric acid and methanesulfonic acid. These salts can be formed by ordinary methods.

Además, el compuesto de la fórmula (I) no está limitado a un isómero específico, sino que incluye todos los posibles In addition, the compound of the formula (I) is not limited to a specific isomer, but includes all possible

20 isómeros, tales como isómeros ceto-enol, isómeros de imina-enamina, diastereoisómeros, isómeros ópticos e isómeros de rotación; y racemato. Por ejemplo, el compuesto de la fórmula (I) en la que R2a es hidrógeno, incluye los siguientes tautómeros. 20 isomers, such as keto-enol isomers, imine-enamine isomers, diastereoisomers, optical isomers and rotation isomers; and racemate. For example, the compound of the formula (I) in which R2a is hydrogen, includes the following tautomers.

[Formula Química 35] [Chemical Formula 35]

30 30

imagen27image27

como Pd/C, en presencia o ausencia de una base. Otros métodos adecuados para preparar compuestos tritiados se pueden encontrar en Isotopes in the Physical and Biomedical Sciences, Vol. I, Labeled Compounds (Parte A) Capítulo 6 (1987). Compuestos marcados con 14C se pueden preparar mediante el empleo de materiales de partida que tienen un carbono 14C. as Pd / C, in the presence or absence of a base. Other suitable methods for preparing tritiated compounds can be found in Isotopes in the Physical and Biomedical Sciences, Vol. I, Labeled Compounds (Part A) Chapter 6 (1987). Compounds marked with 14C can be prepared by using starting materials that have a 14C carbon.

5 (Procedimientos Generales) 5 (General Procedures)

Los compuestos de las fórmulas (I) y (Ia) a (If) de la presente invención se pueden preparar por los métodos descritos a continuación. En las etapas siguientes, cuando se posee un sustituyente que interfiere con la reacción, p. ej., hidroxi, mercapto, amino, formilo, carbonilo, carboxi, el sustituyente está protegido por el método tal como los descritos de antemano en Protective Groups in organic Synthesis, y Theodora W Greene (John Wiley & Sons), y el The compounds of formulas (I) and (Ia) to (If) of the present invention can be prepared by the methods described below. In the following steps, when there is a substituent that interferes with the reaction, e.g. For example, hydroxy, mercapto, amino, formyl, carbonyl, carboxy, the substituent is protected by the method as described in advance in Protective Groups in organic Synthesis, and Theodora W Greene (John Wiley & Sons), and the

10 grupo protector se puede separar en una etapa conveniente. 10 protecting group can be separated at a convenient stage.

1) Síntesis del Compuesto (Ia) 1) Synthesis of Compound (Ia)

[Formula Química 38] [Chemical Formula 38]

imagen28image28

15 en donde cada símbolo es como se ha definido anteriormente. 15 where each symbol is as defined above.

Etapa 1. Stage 1.

Compuesto b se puede preparar añadiendo un reactivo de titanio tal como triisopropóxido de clorotitanio a enolato, que se obtiene por reacción de un éster objetivo tal como propionato de etilo en presencia de una base tal como diisopropilamida de litio en un disolvente tal como tolueno, diclorometano y tetrahidrofurano, o un disolvente mixto de Compound b can be prepared by adding a titanium reagent such as chlorotitanium triisopropoxide to enolate, which is obtained by reacting an objective ester such as ethyl propionate in the presence of a base such as lithium diisopropylamide in a solvent such as toluene, dichloromethane and tetrahydrofuran, or a mixed solvent of

20 los mismos, añadiendo un compuesto que se puede preparar por los métodos conocidos y haciéndolos reaccionar a -80°C a 30°C, preferiblemente -80°C a 0°C, durante 0,1 a 24 horas, preferiblemente de 0,1 a 12 horas. 20 by adding a compound that can be prepared by known methods and reacting at -80 ° C to 30 ° C, preferably -80 ° C to 0 ° C, for 0.1 to 24 hours, preferably 0, 1 to 12 hours

Etapa 2 Stage 2

Compuesto c se puede preparar añadiendo un reactivo de Grignard tal como bromuro de metilmagnesio que está disponible comercialmente o se pueden preparar por los métodos conocidos o un reductor tal como borano, 25 borohidruro de sodio e hidruro de litio y aluminio en el Compuesto b en un disolvente tal como dioxano, Compound c can be prepared by adding a Grignard reagent such as methylmagnesium bromide that is commercially available or can be prepared by known methods or a reducer such as borane, sodium borohydride and lithium aluminum hydride in Compound b in a solvent such as dioxane,

32 32

imagen29image29

imagen30image30

imagen31image31

imagen32image32

imagen33image33

imagen34image34

imagen35image35

imagen36image36

imagen37image37

imagen38image38

imagen39image39

imagen40image40

imagen41image41

imagen42image42

imagen43image43

imagen44image44

imagen45image45

imagen46image46

imagen47image47

imagen48image48

imagen49image49

imagen50image50

imagen51image51

imagen52image52

imagen53image53

imagen54image54

imagen55image55

imagen56image56

imagen57image57

imagen58image58

imagen59image59

imagen60image60

imagen61image61

imagen62image62

imagen63image63

imagen64image64

imagen65image65

imagen66image66

imagen67image67

imagen68image68

imagen69image69

imagen70image70

imagen71image71

imagen72image72

imagen73image73

imagen74image74

imagen75image75

imagen76image76

No.
Estructura RMN (disolvente: orden ascendente del valor de desplazamiento) Structure NMR (solvent: ascending order of offset value)

imagen77  image77
imagen78image78 imagen79image79

I-16 I-16
imagen80image80 imagen81image81

I-17 I-17
imagen82image82 imagen83image83

I-18 I-18
imagen84image84 imagen85image85

I-19 I-19
imagen86image86 imagen87image87

[Tabla 1-4] [Table 1-4]

No.
Estructura Nº. Estructura Structure . Structure

I-20 I-20
imagen88 I-28 imagen89 image88 I-28 image89

81 82 [Tabla 1-5] 81 82 [Table 1-5]

No.
Estructura Nº. Estructura Structure . Structure

imagen90  image90
imagen91image91 imagen92image92 imagen93image93

I-21 I-21
imagen94 I-29 imagen95 image94 I-29 image95

I-22 I-22
imagen96 I-30 imagen97 image96 I-30 image97

I-23 I-23
imagen98 I-31 imagen99 image98 I-31 image99

I-24 I-24
imagen100 I-32 imagen101 image100 I-32 image101

I-25 I-25
imagen102 I-33 imagen103 image102 I-33 image103

I-26 I-26
imagen104 I-34 imagen105 image104 I-34 image105

No.
Estructura Nº. Estructura Structure . Structure

imagen106  image106
imagen107image107 imagen108image108 imagen109image109

I-27 I-27
imagen110 I-35 imagen111 image110 I-35 image111

No.
Estructura Nº Estructura Structure  No. Structure

I-36 I-36
imagen112 I-44 imagen113 image112 I-44 image113

I-37 I-37
imagen114 I-45 imagen115 image114 I-45 image115

I-38 I-38
imagen116 I-46 imagen117 image116 I-46 image117

I-39 I-39
imagen118 I-47 imagen119 image118 I-47 image119

83 83

imagen120image120

imagen121image121

imagen122image122

imagen123image123

imagen124image124

imagen125image125

imagen126image126

imagen127image127

imagen128image128

imagen129image129

Claims (11)

imagen1image 1 imagen2image2 imagen3image3 imagen4image4 imagen5image5 imagen6image6 imagen7image7 imagen8image8 imagen9image9 imagen10image10 imagen11image11 R3a R4aR3a R4a en la que y son los mismos como se define en la reivindicación 1, su sal farmacéuticamente aceptable o un solvato del mismo. wherein and are the same as defined in claim 1, its pharmaceutically acceptable salt or a solvate thereof.
11. eleven.
El compuesto de acuerdo con una cualquiera de las reivindicaciones 6 a 10, en donde -Z-es -C(=O)N(R8)-, su 5 sal farmacéuticamente aceptable o un solvato del mismo. The compound according to any one of claims 6 to 10, wherein -Z-is -C (= O) N (R8) -, its pharmaceutically acceptable salt or a solvate thereof.
12. El compuesto de acuerdo con una cualquiera de las reivindicaciones 6 a 11, en donde el anillo A' es benceno sustituido o no sustituido, y el anillo B es piridina sustituida o no sustituida, pirimidina sustituida o no sustituida o pirazina sustituida o no sustituida, su sal farmacéuticamente aceptable o un solvato del mismo. 12. The compound according to any one of claims 6 to 11, wherein the A 'ring is substituted or unsubstituted benzene, and the B ring is substituted or unsubstituted pyridine, substituted or unsubstituted pyrimidine or substituted or unsubstituted pyrazine substituted, its pharmaceutically acceptable salt or a solvate thereof.
13. 13.
El compuesto de acuerdo con una cualquiera de las reivindicaciones 1 a 9, 11 y 12, en donde R4a y R4b son 10 ambos hidrógeno, su sal farmacéuticamente aceptable o un solvato del mismo. The compound according to any one of claims 1 to 9, 11 and 12, wherein R4a and R4b are both hydrogen, its pharmaceutically acceptable salt or a solvate thereof.
14. 14.
El compuesto de acuerdo con una cualquiera de las reivindicaciones 1 a 3 y 5 a 13, en donde R1 es alquilo C1 a C3 no sustituido, su sal farmacéuticamente aceptable o un solvato del mismo. The compound according to any one of claims 1 to 3 and 5 to 13, wherein R1 is unsubstituted C1 to C3 alkyl, its pharmaceutically acceptable salt or a solvate thereof.
15. fifteen.
El compuesto de acuerdo con una cualquiera de las reivindicaciones 1 a 14, en donde R2a y R2b son ambos hidrógeno, su sal farmacéuticamente aceptable o un solvato del mismo. The compound according to any one of claims 1 to 14, wherein R2a and R2b are both hydrogen, its pharmaceutically acceptable salt or a solvate thereof.
15 16. Una composición farmacéutica que comprende el compuesto de acuerdo con una cualquiera de las reivindicaciones 1 a 15, su sal farmacéuticamente aceptable o un solvato del mismo como un ingrediente activo. 16. A pharmaceutical composition comprising the compound according to any one of claims 1 to 15, its pharmaceutically acceptable salt or a solvate thereof as an active ingredient.
17. La composición farmacéutica de acuerdo con la reivindicación 16, en donde la composición tiene actividad inhibidora de BACE1. 17. The pharmaceutical composition according to claim 16, wherein the composition has BACE1 inhibitory activity. 18. El compuesto de acuerdo con una cualquiera de las reivindicaciones 1 a 15, su sal farmacéuticamente aceptable 20 o un solvato del mismo para uso en un método para inhibir la actividad de BACE1. 18. The compound according to any one of claims 1 to 15, its pharmaceutically acceptable salt 20 or a solvate thereof for use in a method for inhibiting the activity of BACE1. 19. El compuesto de acuerdo con una cualquiera de las reivindicaciones 1 a 15, su sal farmacéuticamente aceptable 19. The compound according to any one of claims 1 to 15, its pharmaceutically acceptable salt o un solvato del mismo en donde la fórmula está representada por: or a solvate thereof where the formula is represented by: imagen12image12 20. Un compuesto de fórmula (I): 20. A compound of formula (I): 104 104 imagen13image13 en donde el anillo A es un carbociclo sustituido o un heterociclo sustituido o no sustituido, R1 es alquilo sustituido o no sustituido, alquenilo sustituido o no sustituido, alquinilo sustituido o no sustituido, acilo sustituido o no sustituido, ciano, carboxi, alcoxicarbonilo sustituido o no sustituido, alqueniloxicarbonilo sustituido o no sustituido, alquiniloxicarbonilo sustituido o no sustituido o carbamoílo sustituido o no sustituido, tiocarbamoilo sustituido o no sustituido, un grupo carbocíclico sustituido o no sustituido, un grupo heterocíclico sustituido o no sustituido, R2a y R2b son, cada uno independientemente, hidrógeno, alquilo sustituido o no sustituido, acilo sustituido wherein ring A is a substituted carbocycle or a substituted or unsubstituted heterocycle, R1 is substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, substituted or unsubstituted acyl, cyano, carboxy, substituted alkoxycarbonyl or unsubstituted, substituted or unsubstituted alkenyloxycarbonyl, substituted or unsubstituted alkynyloxycarbonyl or substituted or unsubstituted carbamoyl, substituted or unsubstituted thiocarbamoyl, a substituted or unsubstituted carbocyclic group, a substituted or unsubstituted heterocyclic group, R2a and R2b are each independently, hydrogen, substituted or unsubstituted alkyl, substituted acyl o no sustituido, alcoxicarbonilo sustituido o no sustituido o carbamoílo sustituido o no sustituido, or unsubstituted, substituted or unsubstituted alkoxycarbonyl or substituted or unsubstituted carbamoyl, imagen14image14 en la que Rza y Rzb son, cada uno independientemente, hidrógeno, halógeno, alquilo sustituido o no sustituido, alquenilo sustituido o no sustituido, alquinilo sustituido o no sustituido, alcoxi sustituido o no sustituido, alqueniloxi sustituido o no sustituido, alquiniloxi sustituido o no sustituido, alquiltio sustituido o no sustituido, alqueniltio sustituido wherein Rza and Rzb are each independently hydrogen, halogen, substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, substituted or unsubstituted alkoxy, substituted or unsubstituted alkenyloxy, substituted or unsubstituted alkynyloxy substituted, substituted or unsubstituted alkylthio, substituted alkenylthio o no sustituido, alquiniltio sustituido o no sustituido, acilo sustituido o no sustituido, carboxi, alcoxicarbonilo sustituido or unsubstituted, substituted or unsubstituted alkynylthio, substituted or unsubstituted acyl, carboxy, substituted alkoxycarbonyl 15 o no sustituido, alqueniloxicarbonilo sustituido o no sustituido, alquiniloxicarbonilo sustituido o no sustituido, amino sustituido o no sustituido, carbamoílo sustituido o no sustituido, tiocarbamoílo sustituido o no sustituido, un grupo carbocíclico sustituido o no sustituido, carbocicliloxi sustituido o no sustituido, carbocicliltio sustituido o no sustituido, carbociclilalquilo sustituido o no sustituido. carbociclilalcoxi sustituido o no sustituido, carbocicliloxicarbonilo sustituido o no sustituido, un grupo heterocíclico sustituido o no sustituido, heterocicliloxi sustituido o no sustituido, 15 or unsubstituted, substituted or unsubstituted alkenyloxycarbonyl, substituted or unsubstituted alkynyloxycarbonyl, substituted or unsubstituted amino, substituted or unsubstituted carbamoyl, substituted or unsubstituted thiocarbamoyl, a substituted or unsubstituted carbocyclic group, carbocyclyl substituted or unsubstituted, carbocyclic substituted or unsubstituted, substituted or unsubstituted carbocyclylalkyl. substituted or unsubstituted carbocyclylalkoxy, substituted or unsubstituted carbocyclyloxycarbonyl, a substituted or unsubstituted heterocyclic group, substituted or unsubstituted heterocyclyloxy, 20 heterocicliltio sustituido o no sustituido, heterociclilalquilo sustituido o no sustituido, heterociclilalcoxi no sustituido o sustituido, heterocicliloxicarbonilo sustituido o no sustituido, o Rza y Rzb, junto con el átomo de carbono al que están unidos, pueden formar un carbociclo no aromático sustituido o no sustituido o un heterociclo no aromático sustituido 20 substituted or unsubstituted heterocyclylthio, substituted or unsubstituted heterocyclylalkyl, unsubstituted or substituted heterocyclylalkoxy, substituted or unsubstituted heterocyclyloxycarbonyl, or Rza and Rzb, together with the carbon atom to which they are attached, may form a substituted or non-aromatic carbocycle substituted or a substituted non-aromatic heterocycle o no sustituido, R3a, R3b, R3c, R4a, R4b y R4c son, cada uno independientemente, hidrógeno, halógeno, hidroxi, alquilo sustituido o no or unsubstituted, R3a, R3b, R3c, R4a, R4b and R4c are each independently hydrogen, halogen, hydroxy, alkyl substituted or not 25 sustituido, alquenilo sustituido o no sustituido, alquinilo sustituido o no sustituido, alcoxi sustituido o no sustituido, alqueniloxi sustituido o no sustituido o alquiniloxi sustituido o no sustituido, alquiltio sustituido o no sustituido, alqueniltio sustituido o no sustituido, alquiniltio sustituido o no sustituido, acilo sustituido o no sustituido, aciloxi sustituido o no sustituido, ciano, nitro, carboxi, alcoxicarbonilo sustituido o no sustituido, alqueniloxicarbonilo sustituido o no sustituido, alquiniloxicarbonilo sustituido o no sustituido, amino sustituido o no sustituido, carbamoílo 25 substituted, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, substituted or unsubstituted alkoxy, substituted or unsubstituted alkynyloxy or substituted or unsubstituted alkynyloxy, substituted or unsubstituted alkylthio, substituted or unsubstituted alkenylthio, substituted or unsubstituted alkynylthio , substituted or unsubstituted acyl, substituted or unsubstituted acyloxy, cyano, nitro, carboxy, substituted or unsubstituted alkoxycarbonyl, substituted or unsubstituted alkenyloxycarbonyl, substituted or unsubstituted alkynyloxycarbonyl, substituted or unsubstituted amino, carbamoyl 30 sustituido o no sustituido, tiocarbamoílo sustituido o no sustituido, sulfamoílo sustituido o no sustituido, alquilsulfinilo sustituido o no sustituido, alquenilsulfinilo sustituido o no sustituido, alquinilsulfinilo sustituido o no sustituido, alquilsulfonilo sustituido o no sustituido, alquenilsulfonilo sustituido o no sustituido, alquinilsulfonilo sustituido o no sustituido, un grupo carbocíclico sustituido o no sustituido, carbocicliloxi sustituido o no sustituido, carbocicliltio sustituido o no sustituido, carbociclilalquilo sustituido o no sustituido, carbociclilalcoxi sustituido o no sustituido, 30 substituted or unsubstituted, substituted or unsubstituted thiocarbamoyl, substituted or unsubstituted sulfamoyl, substituted or unsubstituted alkylsulfinyl, substituted or unsubstituted alkenylsulfinyl, substituted or unsubstituted alkylsulfinyl, substituted or unsubstituted alkylsulfonyl, substituted or unsubstituted alkylsulfonyl or unsubstituted, a substituted or unsubstituted carbocyclic group, substituted or unsubstituted carbocyclyloxy, substituted or unsubstituted carbocyclylthio, substituted or unsubstituted carbocyclylalkyl, substituted or unsubstituted carbocyclylalkoxy, 35 carbocicliloxicarbonilo sustituido o no sustituido, carbociclilsulfinilo sustituido o no sustituido, carbociclilsulfonilo sustituido o no sustituido, un grupo heterocíclico sustituido o no sustituido, heterocicliloxi sustituido o no sustituido, heterocicliltio sustituido o no sustituido, heterociclilalquilo sustituido o no sustituido, heterociclilalcoxi sustituido o no sustituido, heterocicliloxicarbonilo sustituido o no sustituido, heterociclilsulfinilo sustituido o no sustituido o heterociclilsulfonilo sustituido o no sustituido, 35 substituted or unsubstituted carbocyclyloxycarbonyl, substituted or unsubstituted carbocyclylsulfinyl, substituted or unsubstituted carbocyclylsulfonyl, a substituted or unsubstituted heterocyclic group, substituted or unsubstituted heterocyclyloxy, substituted or unsubstituted heterocyclyl, substituted or unsubstituted heterocyclyl , substituted or unsubstituted heterocyclyloxycarbonyl, substituted or unsubstituted heterocyclylsulfinyl or substituted or unsubstituted heterocyclylsulfonyl, 40 R3a y R3b, junto con el átomo de carbono al que están unidos, pueden formar un carbociclo sustituido o no sustituido R3a and R3b, together with the carbon atom to which they are attached, can form a substituted or unsubstituted carbocycle
o un heterociclo sustituido o no sustituido, R4a y R4b, junto con el átomo de carbono al que están unidos, pueden formar un carbociclo sustituido o no sustituido or a substituted or unsubstituted heterocycle, R4a and R4b, together with the carbon atom to which they are attached, can form a substituted or unsubstituted carbocycle
o un heterociclo sustituido o no sustituido, or a substituted or unsubstituted heterocycle,
105 105 el anillo Q es un carbociclo sustituido o no sustituido, o un heterociclo sustituido o no sustituido, la línea discontinua a, la línea discontinua b y la línea discontinua c significa cada una de forma independiente la presencia o ausencia de un enlace, cuando una línea discontinua a significa la presencia de un enlace, entonces R3b y R4b están ausentes, cuando la línea discontinua b significa la presencia de un enlace, entonces R3c está ausente cuando la línea discontinua c significa la presencia de un enlace, entonces R4c está ausente, Y1 e Y2 son, cada uno independientemente ,-C(R5)(R6)-, -C(R5)=, -N(R7)-, -N=, -S-, -SO-, -SO2-u -O-, Y3 e Y4 son, cada uno independientemente, -C(R5)(R6)-, N(R7)-, -S-, -SO-, -SO2-u -O-, R5 y R6 son, cada uno independientemente, hidrógeno, halógeno, hidroxi, alquilo sustituido o no sustituido, alquenilo sustituido o no sustituido, alquinilo sustituido o no sustituido, alcoxi sustituido o no sustituido, alqueniloxi sustituido the Q ring is a substituted or unsubstituted carbocycle, or a substituted or unsubstituted heterocycle, the broken line a, the broken line b and the broken line c each independently means the presence or absence of a bond, when a broken line a means the presence of a link, then R3b and R4b are absent, when the broken line b means the presence of a link, then R3c is absent when the broken line c means the presence of a link, then R4c is absent, Y1 e Y2 are, each independently, -C (R5) (R6) -, -C (R5) =, -N (R7) -, -N =, -S-, -SO-, -SO2-u -O- , Y3 and Y4 are, each independently, -C (R5) (R6) -, N (R7) -, -S-, -SO-, -SO2-u -O-, R5 and R6 are, each independently , hydrogen, halogen, hydroxy, substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, substituted or unsubstituted alkoxy, substituted alkenyloxy
o no sustituido, alquiniloxi sustituido o no sustituido, alquiltio sustituido o no sustituido, alqueniltio sustituido o no sustituido, alquiniltio sustituido o no sustituido, acilo sustituido o no sustituido, aciloxi sustituido o no sustituido, ciano, nitro, carboxi, alcoxicarbonilo sustituido o no sustituido, alqueniloxicarbonilo sustituido o no sustituido, alquiniloxicarbonilo, amino sustituido o no sustituido, carbamoílo sustituido o no sustituido, tiocarbamoílo sustituido o no sustituido, sulfamoílo sustituido o no sustituido, alquilsulfinilo sustituido o no sustituido, alquenilsulfinilo sustituido or unsubstituted, substituted or unsubstituted alkynyloxy, substituted or unsubstituted alkylthio, substituted or unsubstituted alkenylthio, substituted or unsubstituted alkynylthio, substituted or unsubstituted acyl, substituted or unsubstituted acyloxy, cyano, nitro, carboxy, substituted or unsubstituted alkoxycarbonyl substituted, substituted or unsubstituted alkenyloxycarbonyl, alkynyloxycarbonyl, substituted or unsubstituted amino, substituted or unsubstituted carbamoyl, substituted or unsubstituted thiocarbamoyl, substituted or unsubstituted sulfamoyl, substituted or unsubstituted alkylsulfinyl, substituted alkenylsulfinyl
o no sustituido, alquinilsulfinilo sustituido o no sustituido, alquilsulfonilo sustituido o no sustituido, alquenilsulfonilo sustituido o no sustituido, alquinilsulfonilo sustituido o no sustituido, un grupo carbocíclico sustituido o no sustituido, carbocicliloxi sustituido o no sustituido, carbocicliltiio sustituido o no sustituido, carbociclilalquilo sustituido o no sustituido, carbociclilalcoxi sustituido o no sustituido, carbocicliloxicarbonilo sustituido o no sustituido, carbociclilsulfinilo sustituido o no sustituido, carbociclilsulfonilo sustituido o no sustituido, un grupo heterocíclico sustituido o no sustituido, heterocicliloxi sustituido o no sustituido, heterocicliltio sustituido o no sustituido, heterociclilalquilo sustituido o no sustituido, heterociclilalcoxi sustituido o no sustituido, heterocicliloxicarbonilo sustituido o no sustituido, heterociclilsulfinilo sustituido o no sustituido, heterociclilsulfonilo sustituido o no sustituido y R7 es hidrógeno, halógeno, hidroxi, alquilo sustituido o no sustituido, alquenilo sustituido o no sustituido, alquinilo sustituido o no sustituido, alcoxi sustituido o no sustituido, alqueniloxi sustituido o no sustituido, alquiniloxi sustituido or unsubstituted, substituted or unsubstituted alkylsulfinyl, substituted or unsubstituted alkylsulfonyl, substituted or unsubstituted alkenylsulfonyl, substituted or unsubstituted alkylsulfonyl, a substituted or unsubstituted carbocyclic group, substituted or unsubstituted carbocyclyloxy, substituted or unsubstituted carbocyclyl, substituted or unsubstituted carbocyclyl or unsubstituted, substituted or unsubstituted carbocyclylalkoxy, substituted or unsubstituted carbocyclyloxycarbonyl, substituted or unsubstituted carbocyclylsulfinyl, substituted or unsubstituted carbocyclylsulfonyl, a substituted or unsubstituted heterocyclyl group, substituted or unsubstituted heterocyclyl or substituted heterocyclyl or unsubstituted, substituted or unsubstituted heterocyclylalkoxy, substituted or unsubstituted heterocyclyloxycarbonyl, substituted or unsubstituted heterocyclylsulfinyl, substituted or unsubstituted heterocyclylsulfonyl and R7 is hydrogen, halogen, hi droxy, substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, substituted or unsubstituted alkoxy, substituted or unsubstituted alkenyloxy, substituted alkynyloxy
o no sustituido, acilo sustituido o no sustituido, aciloxi sustituido o no sustituido, ciano, nitro, carboxi, alcoxicarbonilo sustituido o no sustituido, alqueniloxicarbonilo sustituido o no sustituido, alquiniloxicarbonilo sustituido o no sustituido, alquilsulfinilo sustituido o no sustituido, alquenilsulfinilo sustituido o no sustituido, alquinilsulfinilo sustituido or unsubstituted, substituted or unsubstituted acyl, substituted or unsubstituted acyloxy, cyano, nitro, carboxy, substituted or unsubstituted alkoxycarbonyl, substituted or unsubstituted alkenyloxycarbonyl, substituted or unsubstituted alkynyloxycarbonyl, substituted or unsubstituted alkylsulfinyl, substituted or alkenylsulfinyl substituted, substituted alkylsulfinyl
o no sustituido, alquilsulfonilo sustituido o no sustituido, alquenilsulfonilo sustituido o no sustituido, alquinilsulfonilo sustituido o no sustituido, carbamoílo sustituido o no sustituido, tiocarbamoílo sustituido o no sustituido, sulfamoílo sustituido o no sustituido, amino sustituido o no sustituido, un grupo carbocíclico sustituido o no sustituido, carbocicliloxi sustituido o no sustituido, carbocicliltio sustituido o no sustituido, carbociclilalquilo sustituido o no sustituido, carbociclilalcoxi sustituido o no sustituido, carbocicliloxicarbonilo sustituido o no sustituido, carbociclilsulfinilo sustituido o no sustituido, carbociclilsulfonilo sustituido o no sustituido, un grupo heterocíclico sustituido o no sustituido, heterocicliloxi sustituido o no sustituido, heterocicliltio sustituido o no sustituido, heterociclilalquilo sustituido o no sustituido, heterociclilalcoxi sustituido o no sustituido, heterocicliloxicarbonilo sustituido o no sustituido, heterociclilsulfinilo sustituido o no sustituido o heterociclilsulfonilo sustituido o no sustituido, or unsubstituted, substituted or unsubstituted alkylsulfonyl, substituted or unsubstituted alkenylsulfonyl, substituted or unsubstituted alkylsulfonyl, substituted or unsubstituted carbamoyl, substituted or unsubstituted thiocarbamoyl, substituted or unsubstituted sulfamoyl, a substituted carbocyclic group or unsubstituted, substituted or unsubstituted carbocyclyloxy, substituted or unsubstituted carbocyclylthio, substituted or unsubstituted carbocyclylalkyl, substituted or unsubstituted carbocyclylalkoxy, substituted or unsubstituted carbocyclyloxycarbonyl, substituted or unsubstituted carbocyclyl, substituted heterocyclic or unsaturated carbocyclic or unsubstituted, substituted or unsubstituted heterocyclyloxy, substituted or unsubstituted heterocyclylthio, substituted or unsubstituted heterocyclylalkyl, substituted or unsubstituted heterocyclylalkoxy, substituted or unsubstituted heterocyclyloxycarbonyl, heterocyclylsulfinyl substituted or unsubstituted or substituted or unsubstituted heterocyclylsulfonyl,
los sustituyentes de "carbociclo sustituido" y "heterociclo sustituido o no sustituido" en el anillo A, el anillo A' y el anillo B the "substituted carbocycle" and "substituted or unsubstituted heterocycle" substituents on ring A, ring A 'and ring B "alquilo sustituido o no sustituido", "alcoxi sustituido o no sustituido", "alcoxicarbonilo sustituido o no sustituido", "alquiltio sustituido o no sustituido", "alquilsulfonilo sustituido o no sustituido", "alquilsulfinilo sustituido o no sustituido", "alquenilo sustituido o no sustituido", "alqueniloxi sustituido o no sustituido", "alqueniloxicarbonilo sustituido o no sustituido", "alqueniltio sustituido o no sustituido", "alquenilsulfinilo sustituido o no sustituido", "alquenilsulfonilo sustituido o no sustituido", "alquinilo sustituido o no sustituido", "alquiniloxi sustituido o no sustituido", "alquiniltio sustituido o no sustituido", "alquiniloxicarbonilo sustituido o no sustituido", "alquinilsulfinilo sustituido o no sustituido", "alquinilsulfonilo sustituido o no sustituido", "alquileno sustituido o no sustituido", "alquenileno sustituido o no sustituido", "alquinileno sustituido o no sustituido", "acilo sustituido o no sustituido", "aciloxi sustituido o no sustituido", "amino sustituido o no sustituido", "carbamoílo sustituido o no sustituido", "tiocarbamoílo sustituido o no sustituido", "sulfamoílo sustituido o no sustituido", los sustituyentes de "grupo carbocíclico sustituido o no sustituido", "carbocicliltio sustituido o no sustituido", "carbocicliloxicarbonilo sustituido o no sustituido", "carbocicliloxi sustituido o no sustituido", "carbociclilsulfinilo sustituido o no sustituido", "carbociclilsulfonilo sustituido o no sustituido", "heterociclilo sustituido o no sustituido", "heterocicliloxi sustituido o no sustituido", "heterocicliltio sustituido o no sustituido", "heterocicliloxicarbonilo sustituido o no sustituido", "heterociclilsulfinilo sustituido o no sustituido" y "heterociclilsulfonilo sustituido o no sustituido" "substituted or unsubstituted alkyl", "substituted or unsubstituted alkoxy", "substituted or unsubstituted alkoxycarbonyl", "substituted or unsubstituted alkylthio", "substituted or unsubstituted alkylsulfonyl", "substituted or unsubstituted alkylsulfinyl", "alkenyl substituted or unsubstituted "," substituted or unsubstituted alkenyloxy "," substituted or unsubstituted alkenyloxycarbonyl "," substituted or unsubstituted alkenylthio "," substituted or unsubstituted alkenylsulfinyl "," substituted or unsubstituted alkenyl sulfonyl "," substituted or alkynyl unsubstituted "," substituted or unsubstituted alkynyloxy "," substituted or unsubstituted alkynylthio "," substituted or unsubstituted alkynyloxycarbonyl "," substituted or unsubstituted alkynylsulfinyl "," substituted or unsubstituted alkylsulfonyl "," substituted or unsubstituted alkylene "," substituted or unsubstituted alkenylene "," substituted or unsubstituted alkynylene "," substituted or unsubstituted acyl "," substituted or unsubstituted acyloxy "," amino substituted or unsubstituted "," substituted or unsubstituted carbamoyl "," substituted or unsubstituted thiocarbamoyl "," substituted or unsubstituted sulfamoyl ", the substituents of" substituted or unsubstituted carbocyclic group "," substituted or unsubstituted carbocyclylthio ", "substituted or unsubstituted carbocyclyloxycarbonyl", "substituted or unsubstituted carbocyclyloxy", "substituted or unsubstituted carbocyclylsulfinyl", "substituted or unsubstituted carbocyclylsulfonyl", "substituted or unsubstituted heterocyclyloyl", "heterocyclyl substituted or unsubstituted" substituted or unsubstituted "," substituted or unsubstituted heterocyclyloxycarbonyl "," substituted or unsubstituted heterocyclylsulfinyl "and" substituted or unsubstituted heterocyclylsulfonyl " en otro que no sea el anillo A, el anillo A' y el anillo B son, si están presentes, los mismos como se definen en la reivindicación 1, excluyendo los compuestos en donde in another than ring A, ring A 'and ring B are, if present, the same as defined in claim 1, excluding compounds wherein 106 106 imagen15image15 y el anillo A es and ring A is imagen16image16 en el que el anillo A' y el anillo B son, cada uno independientemente, un carbociclo sustituido o no sustituido o un heterociclo sustituido o no sustituido, Z es –L1 ‘ -N(R8) -L2'-, L1 ' y L2' son, cada uno independientemente, un enlace; alquileno sustituido o no sustituido, en donde el sustituyente es uno o más seleccionados de halógeno, alcoxi, haloalcoxi, hidroxialcoxi, alcoxialcoxi, acilo, aciloxi, carboxi, alcoxicarbonilo, amino, acilamino, alquilamino, imino, hidroxiimino, alcoxiimino, alquiltio, carbamoilo, alquilcarbamoilo, hidroxialquilcarbamoilo, sulfamoilo, alquilsulfamoilo, alquilsulfinilo, alquilsulfonilamino, alquilsulfonilalquilamino, alquilsulfonilimino, alquilsulfinilamino, alquilsulfinilalquilamino, alquilsulfinilimino, ciano, nitro, un grupo carbocíclico y un grupo heterocíclico, cada uno de los cuales carbociclo y heterociclo está opcionalmente sustituido con uno o más sustituyentes seleccionados de halógeno, alquilo, hidroxi y alcoxi; alquenileno sustituido o no sustituido, en donde el sustituyente es uno o más seleccionados de halógeno, alcoxi, haloalcoxi, hidroxialcoxi, alcoxialcoxi, acilo, aciloxi, carboxi, alcoxicarbonilo, amino, acilamino, alquilamino, imino, hidroxiimino, alcoxiimino, alquiltio, carbamoilo, alquilcarbamoilo, hidroxialquilcarbamoilo, sulfamoilo, alquilsulfamoilo, alquilsulfinilo, alquilsulfonilamino, alquilsulfonilalquilamino, alquilsulfonilimino, alquilsulfinilamino, alquilsulfinilalquilamino, alquilsulfinilimino, ciano, nitro, un grupo carbocíclico y un grupo heterocíclico, cada uno de los cuales carbociclo y heterociclo está opcionalmente sustituido con uno o más sustituyentes seleccionados de halógeno, alquilo, hidroxi y alcoxi; o alquinileno sustituido o no sustituido, en donde el sustituyente es uno o más seleccionados de halógeno, alcoxi, haloalcoxi, hidroxialcoxi, alcoxialcoxi, acilo, aciloxi, carboxi, alcoxicarbonilo, amino, acilamino, alquilamino, imino, hidroxiimino, alcoxiimino, alquiltio, carbamoilo, alquilcarbamoilo, hidroxialquilcarbamoílo, sulfamoilo, alquilsulfamoilo, alquilsulfinilo, alquilsulfonilamino, alquilsulfonilalquilamino, alquilsulfonilimino, alquilsulfinilamino, alquilsulfinilalquilamino, alquilsulfinilimino, ciano, nitro, un grupo carbocíclico y un grupo heterocíclico, cada uno de los cuales carbociclo y heterociclo está opcionalmente sustituido con uno o más sustituyentes seleccionados de halógeno, alquilo, hidroxi y alcoxi; y R8 es hidrógeno, alquilo sustituido o no sustituido, alquenilo sustituido o no sustituido, alquinilo sustituido o no sustituido o acilo sustituido o no sustituido, wherein ring A 'and ring B are each independently a substituted or unsubstituted carbocycle or a substituted or unsubstituted heterocycle, Z is -L1' -N (R8) -L2'-, L1 'and L2 'are, each independently, a link; substituted or unsubstituted alkylene, wherein the substituent is one or more selected from halogen, alkoxy, haloalkoxy, hydroxyalkoxy, alkoxyalkoxy, acyl, acyloxy, carboxy, alkoxycarbonyl, amino, acylamino, alkylamino, imino, hydroxyimino, alkoxyimino, alkylthio, carbamoyl, alkylcarbamoyl, hydroxyalkylcarbamoyl, sulfamoyl, alkylsulfamoyl, alkylsulfinyl, alkylsulfonylamino, alkylsulfonylalkylamino, alkylsulfonylimino, alkylsulfinylamino, alkylsulphinyl alkylamino, alkylsulfinylimino, cyano, nitro, a carbocyclic group and an optionally substituted heterocyclic group selected from halogen, alkyl, hydroxy and alkoxy; substituted or unsubstituted alkenylene, wherein the substituent is one or more selected from halogen, alkoxy, haloalkoxy, hydroxyalkoxy, alkoxyalkoxy, acyl, acyloxy, carboxy, alkoxycarbonyl, amino, acylamino, alkylamino, imino, hydroxyimino, alkoxyimino, alkylthio, carbamoyl, alkylcarbamoyl, hydroxyalkylcarbamoyl, sulfamoyl, alkylsulfamoyl, alkylsulfinyl, alkylsulfonylamino, alkylsulfonylalkylamino, alkylsulfonylimino, alkylsulfinylamino, alkylsulphinyl alkylamino, alkylsulfinylimino, cyano, nitro, a carbocyclic group and an optionally substituted heterocyclic group selected from halogen, alkyl, hydroxy and alkoxy; or substituted or unsubstituted alkynylene, wherein the substituent is one or more selected from halogen, alkoxy, haloalkoxy, hydroxyalkoxy, alkoxyalkoxy, acyl, acyloxy, carboxy, alkoxycarbonyl, amino, acylamino, alkylamino, imino, hydroxyimino, alkoxyimino, alkylthio, carbamoyl , alkylcarbamoyl, hydroxyalkylcarbamoyl, sulfamoyl, alkylsulfamoyl, alkylsulfinyl, alkylsulfonylamino, alkylsulfonylalkylamino, alkylsulfonylimino, alkylsulfinylamino, alkylsulfinyl alkylamino, alkylsulfinylimino, cyano, nitro, a carbocyclic group and one heterocyclic group, each of which is optionally substituted with one heterocyclic group substituents selected from halogen, alkyl, hydroxy and alkoxy; and R8 is hydrogen, substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl or substituted or unsubstituted acyl, su sal farmacéuticamente aceptable o un solvato del mismo para uso en el tratamiento y/o prevención de la demencia del tipo de Alzheimer, síndrome de Down, deterioro de la memoria, enfermedad de priones (enfermedad de Creutzfeldt-Jakob) , deterioro cognitivo leve (MCI), tipo holandés de la hemorragia cerebral hereditaria con amiloidosis, angiopatía amiloide cerebral, otro tipo de demencia degenerativa, demencia mixta con la enfermedad de Alzheimer y el tipo vascular, demencia con la enfermedad de Parkinson, demencia con parálisis supranuclear progresiva, demencia con corticotropina degeneración basal, enfermedad de Alzheimer con enfermedad difusa de cuerpos de Lewy, degeneración macular relacionada con la edad, enfermedad de Parkinson, o la angiopatía amiloide. its pharmaceutically acceptable salt or solvate thereof for use in the treatment and / or prevention of Alzheimer's type dementia, Down syndrome, memory impairment, prion disease (Creutzfeldt-Jakob disease), mild cognitive impairment ( MCI), Dutch type of hereditary cerebral hemorrhage with amyloidosis, cerebral amyloid angiopathy, other degenerative dementia, mixed dementia with Alzheimer's disease and vascular type, dementia with Parkinson's disease, dementia with progressive supranuclear paralysis, dementia with Basal degeneration corticotropin, Alzheimer's disease with diffuse Lewy body disease, age-related macular degeneration, Parkinson's disease, or amyloid angiopathy.
21. El compuesto para uso de acuerdo con la reivindicación 20, representado por la fórmula (Iα): 21. The compound for use according to claim 20, represented by the formula (Iα): 107 107 imagen17image17 imagen18image18 imagen19image19
ES10836054T 2009-12-11 2010-12-10 Oxazine derivative Active ES2590038T5 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2009282184 2009-12-11
JP2009282184 2009-12-11
JP2010237030 2010-10-22
JP2010237030 2010-10-22
PCT/JP2010/072193 WO2011071135A1 (en) 2009-12-11 2010-12-10 Oxazine derivative

Publications (2)

Publication Number Publication Date
ES2590038T3 true ES2590038T3 (en) 2016-11-17
ES2590038T5 ES2590038T5 (en) 2021-10-19

Family

ID=44145678

Family Applications (1)

Application Number Title Priority Date Filing Date
ES10836054T Active ES2590038T5 (en) 2009-12-11 2010-12-10 Oxazine derivative

Country Status (15)

Country Link
US (3) US8999980B2 (en)
EP (1) EP2511268B2 (en)
JP (2) JPWO2011071135A1 (en)
KR (1) KR20120104570A (en)
CN (1) CN102834384A (en)
AU (1) AU2010328975B2 (en)
BR (1) BR112012013854A2 (en)
CA (1) CA2783958A1 (en)
ES (1) ES2590038T5 (en)
MX (1) MX2012006491A (en)
RU (1) RU2012129168A (en)
TW (1) TWI488852B (en)
UA (1) UA110467C2 (en)
WO (1) WO2011071135A1 (en)
ZA (2) ZA201203777B (en)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7763609B2 (en) 2003-12-15 2010-07-27 Schering Corporation Heterocyclic aspartyl protease inhibitors
BRPI0617852A2 (en) 2005-10-25 2011-08-09 Shionogi & Co aminodihydrothiazine derivatives as well as compositions containing them
AU2008245082B8 (en) 2007-04-24 2012-09-13 Shionogi & Co., Ltd. Aminodihydrothiazine derivatives substituted with a cyclic group
WO2008133273A1 (en) 2007-04-24 2008-11-06 Shionogi & Co., Ltd. Pharmaceutical composition for treatment of alzheimer's disease
NZ589590A (en) 2008-06-13 2012-05-25 Shionogi & Co Sulfur-containing heterocyclic derivative having beta-secretase-inhibiting activity
JPWO2010047372A1 (en) 2008-10-22 2012-03-22 塩野義製薬株式会社 2-Aminopyrimidin-4-one and 2-aminopyridine derivatives having BACE1 inhibitory activity
UY32799A (en) 2009-07-24 2011-02-28 Novartis Ag DERIVATIVES OF OXAZINE AND ITS USE IN THE TREATMENT OF NEUROLOGICAL DISORDERS
UA108363C2 (en) 2009-10-08 2015-04-27 IMINOTIADIASIADIOXIDE OXIDES AS BACE INHIBITORS, COMPOSITIONS THEREOF AND THEIR APPLICATIONS
EP2485590B1 (en) 2009-10-08 2015-01-07 Merck Sharp & Dohme Corp. Pentafluorosulfur imino heterocyclic compounds as bace-1 inhibitors, compositions, and their use
WO2011044185A2 (en) 2009-10-08 2011-04-14 Schering Corporation Pentafluorosulfur imino heterocyclic compounds as bace-1 inhibitors, compositions, and their use
WO2011044187A1 (en) 2009-10-08 2011-04-14 Schering Corporation Iminothiadiazine dioxide compounds as bace inhibitors, compositions, and their use
CA2783958A1 (en) 2009-12-11 2011-06-16 Shionogi & Co., Ltd. Oxazine derivative
EP2580200B1 (en) 2010-06-09 2016-09-14 Janssen Pharmaceutica, N.V. 5,6-dihydro-2h-[1,4]oxazin-3-yl-amine derivatives useful as inhibitors of beta-secretase (bace)
US8927721B2 (en) 2010-10-29 2015-01-06 Shionogi & Co., Ltd. Naphthyridine derivative
US9018219B2 (en) 2010-10-29 2015-04-28 Shionogi & Co., Ltd. Fused aminodihydropyrimidine derivative
SG191097A1 (en) 2010-12-22 2013-08-30 Janssen Pharmaceutica Nv 5,6-DIHYDRO-IMIDAZO[1,2-a]PYRAZIN-8-YLAMINE DERIVATIVES USEFUL AS INHIBITORS OF BETA-SECRETASE (BACE)
US8524897B2 (en) 2011-01-12 2013-09-03 Novartis Ag Crystalline oxazine derivative
SI2663561T1 (en) 2011-01-13 2016-07-29 Novartis Ag Novel heterocyclic derivatives and their use in the treatment of neurological disorders
US8404680B2 (en) * 2011-02-08 2013-03-26 Hoffmann-La Roche Inc. N-[3-(5-amino-3,3a,7,7a-tetrahydro-1H-2,4-dioxa-6-aza-inden-7-yl)-phenyl]-amides as BACE1 and/or BACE2 inhibitors
WO2012117027A1 (en) 2011-03-01 2012-09-07 Janssen Pharmaceutica Nv 6,7-dihydro-pyrazolo[1,5-a]pyrazin-4-ylamine derivatives useful as inhibitors of beta-secretase (bace)
CA2825620C (en) 2011-03-09 2019-04-23 Janssen Pharmaceutica Nv 3,4-dihydro-pyrrolo[1,2-a]pyrazin-1-ylamine derivatives useful as inhibitors of beta-secretase (bace)
EP2694521B1 (en) 2011-04-07 2015-11-25 Merck Sharp & Dohme Corp. Pyrrolidine-fused thiadiazine dioxide compounds as bace inhibitors, compositions, and their use
EP2694489B1 (en) 2011-04-07 2017-09-06 Merck Sharp & Dohme Corp. C5-c6 oxacyclic-fused thiadiazine dioxide compounds as bace inhibitors, compositions, and their use
US8754075B2 (en) * 2011-04-11 2014-06-17 Hoffmann-La Roche Inc. 1,3-oxazines as BACE1 and/or BACE2 inhibitors
EP2703399A4 (en) * 2011-04-26 2014-10-15 Shionogi & Co Oxazine derivative and bace 1 inhibitor containing same
WO2012147762A1 (en) 2011-04-26 2012-11-01 塩野義製薬株式会社 Pyridine derivative and bace-1 inhibitor containing same
US8785436B2 (en) * 2011-05-16 2014-07-22 Hoffmann-La Roche Inc. 1,3-oxazines as BACE 1 and/or BACE2 inhibitors
KR20140041687A (en) 2011-06-07 2014-04-04 에프. 호프만-라 로슈 아게 Halogen-alkyl-1,3 oxazines as bace1 and/or bace2 inhibitors
US9073909B2 (en) * 2011-06-07 2015-07-07 Hoffmann-La Roche Inc. [1,3]oxazines
JP2014524472A (en) 2011-08-22 2014-09-22 メルク・シャープ・アンド・ドーム・コーポレーション 2-Spiro-substituted iminothiazines and their monooxides and dioxides as BACE inhibitors, compositions, and uses thereof
UY34278A (en) 2011-08-25 2013-04-05 Novartis Ag NEW NOXEDINE DERIVATIVES OF OXAZINE AND ITS USE IN THE TREATMENT OF DISEASES
US20130073953A1 (en) * 2011-09-21 2013-03-21 Timothy Onyenobi News headline screenshot viewing system
MX357383B (en) * 2011-12-06 2018-07-06 Janssen Pharmaceutica Nv 5-(3-aminophenyl)-5-alkyl-5,6-dihydro-2h-[1,4]oxazin-3-amine derivatives.
SG11201403956VA (en) * 2012-01-26 2014-10-30 Hoffmann La Roche Fluoromethyl-5,6-dihydro-4h-[1,3]oxazines
US8338413B1 (en) 2012-03-07 2012-12-25 Novartis Ag Oxazine derivatives and their use in the treatment of neurological disorders
MA37763B1 (en) * 2012-06-26 2017-05-31 Hoffmann La Roche Difluoro-hexahydro-cyclopentaoxazinyl and difluoro-hexahydro-benzooxazinyls as bace1 inhibitors
US9556135B2 (en) 2012-10-12 2017-01-31 Amgen, Inc. Amino-dihydrothiazine and amino-dioxido dihydrothiazine compounds as beta-secretase antagonists and methods of use
EP2912035A4 (en) * 2012-10-24 2016-06-15 Shionogi & Co Dihydrooxazine or oxazepine derivatives having bace1 inhibitory activity
WO2014078314A1 (en) 2012-11-15 2014-05-22 Amgen Inc. Amino-oxazine and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use
US9489013B2 (en) 2012-12-20 2016-11-08 Merck Sharp & Dohme Corp. C6-azaspiro iminothiadiazine dioxides as bace inhibitors, compositions, and their use
US9309263B2 (en) 2013-01-29 2016-04-12 Amgen Inc. Fused multi-cyclic sulfone compounds as inhibitors of beta-secretase and methods of use thereof
AU2014223334C1 (en) 2013-03-01 2018-10-18 Amgen Inc. Perfluorinated 5,6-dihydro-4H-1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use
CN105164121A (en) 2013-03-08 2015-12-16 美国安进公司 Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use
KR102247765B1 (en) 2013-04-11 2021-05-06 에프. 호프만-라 로슈 아게 Bace1 inhibitors
KR102243133B1 (en) 2013-06-12 2021-04-22 얀센 파마슈티카 엔.브이. 4-amino-6-phenyl-6,7-dihydro[1,2,3]triazolo[1,5-a]pyrazine derivatives as inhibitors of beta-secretase(bace)
KR102243134B1 (en) 2013-06-12 2021-04-22 얀센 파마슈티카 엔.브이. 4-amino-6-phenyl-5,6-dihydroimidazo[1,5-a]pyrazine derivatives as inhibitors of beta-secretase(bace)
JP6387402B2 (en) 2013-06-12 2018-09-05 ヤンセン ファーマシューティカ エヌ.ベー. 4-Amino-6-phenyl-5,6-dihydroimidazo [1,5-A] pyrazin-3 (2H) -one derivatives as inhibitors of β-secretase (BACE)
JO3318B1 (en) 2013-06-18 2019-03-13 Lilly Co Eli Bace inhibitors
WO2015017407A1 (en) 2013-07-30 2015-02-05 Amgen Inc. Bridged bicyclic amino thiazine dioxide compounds as inhibitors of beta- secretase
WO2015132141A1 (en) * 2014-03-03 2015-09-11 F. Hoffmann-La Roche Ag 1,3-oxazine-2-amine derivatives acting as bace inhibitors for the treatment of alzheimer's disease
TW201623295A (en) * 2014-04-11 2016-07-01 塩野義製藥股份有限公司 Dihydrothiazine and dihydrooxazine derivatives having BACE1 inhibitory activity
WO2016012384A1 (en) * 2014-07-22 2016-01-28 F. Hoffmann-La Roche Ag Trifluormethyloxazine amidines as bace1 inhibitors
MX2017001794A (en) 2014-08-08 2017-06-29 Amgen Inc Cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of use.
ES2768823T3 (en) 2014-12-18 2020-06-23 Janssen Pharmaceutica Nv 2,3,4,5-Tetrahydropyridin-6-amine and 3,4-dihydro-2H-pyrrole-5-amine derivatives useful as beta-secretase inhibitors
US10246429B2 (en) 2015-08-06 2019-04-02 Amgen Inc. Vinyl fluoride cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of use
WO2017061534A1 (en) 2015-10-08 2017-04-13 Shionogi & Co., Ltd. Dihydrothiazine derivatives
MA54101A (en) 2016-12-15 2021-10-27 Amgen Inc BICYCLIC THIAZINE AND OXAZINE DERIVATIVES AS BETA-SECRETASE INHIBITORS AND METHODS OF USE
AU2017378316B2 (en) 2016-12-15 2021-04-01 Amgen Inc. Cyclopropyl fused thiazine derivatives as beta-secretase inhibitors and methods of use
JP7177773B2 (en) * 2016-12-15 2022-11-24 アムジエン・インコーポレーテツド Oxazine derivatives as beta-secretase inhibitors and methods of use
MA54100A (en) 2016-12-15 2021-10-20 Amgen Inc THIAZINE DERIVATIVES AS BETA-SECRETASE INHIBITORS AND METHODS OF USE
US11021493B2 (en) 2016-12-15 2021-06-01 Amgen Inc. 1,4-thiazine dioxide and 1,2,4-thiadiazine dioxide derivatives as beta-secretase inhibitors and methods of use
WO2019208693A1 (en) 2018-04-27 2019-10-31 Shionogi & Co., Ltd. Tetrahydropyranooxazine derivatives having selective bace1 inhibitory activity
JP2022532810A (en) * 2018-07-06 2022-07-20 塩野義製薬株式会社 Condensed heterocyclic derivative with selective BACE1 inhibitory activity

Family Cites Families (223)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2899426A (en) 1959-08-11 Synthesis of l
US3235551A (en) 1966-02-15 Novel derivatives of
US3227713A (en) 1966-01-04 Azine derivatives
JPH09504278A (en) 1944-06-01 1997-04-28 ザ、ウェルカム、ファンデーション、リミテッド Substituted urea and isothiourea derivatives as NO synthase inhibitors
US3115494A (en) 1961-10-13 1963-12-24 Mcneilab Inc 2-amino-5, 6-dihydro-4ii-1, 3-oxazines and a process for their preparation
BE637923A (en) 1962-09-29
US3636116A (en) 1968-09-03 1972-01-18 Dow Chemical Co 1 2-substituted indene compounds
SU465792A3 (en) 1968-11-06 1975-03-30 Хиноин Гиогисцер-Ес Вегиесцети Термекек Гиара Рт (Фирма) The method of obtaining heterocyclic compounds
US3577428A (en) 1969-04-14 1971-05-04 Colgate Palmolive Co 2-amino-4-aryloxyalkyl-4-alkyl-2-oxazolines
US3719674A (en) 1971-02-08 1973-03-06 Dow Chemical Co 1,2-substituted indene compounds
DE2426653C3 (en) 1974-06-01 1982-05-06 Bayer Ag, 5090 Leverkusen Derivatives of 2-amino-1,3-thiazine
DD140144A1 (en) 1978-11-08 1980-02-13 Horst Hartmann PROCESS FOR THE PREPARATION OF P-AMINOPHENYL SUBSTITUTED 2-AMINO-1,3-THIAZINIUM SALTS
US4311840A (en) 1980-11-13 1982-01-19 E. R. Squibb & Sons, Inc. 2,3,6,7-Tetrahydro-2-thioxo-4H-oxazolo[3,2-a]-1,3,5 triazin-4-ones
JPS62120374A (en) 1985-11-20 1987-06-01 Yoshitomi Pharmaceut Ind Ltd 1,3-thiazine or 1,3-oxazine derivative
JPH0231792Y2 (en) 1986-01-21 1990-08-28
FI95572C (en) 1987-06-22 1996-02-26 Eisai Co Ltd Process for the preparation of a medicament useful as a piperidine derivative or its pharmaceutical salt
CA1332151C (en) 1988-01-28 1994-09-27 Roman Amrein Use of a benzamide to treat cognitive disorder
US5236942A (en) 1990-04-19 1993-08-17 Merrell Dow Pharmaceuticals Inc. 5-aryl-4-alkyl-3H-1,2,4-triazole-3-thiones useful in the treatment of Altzheimer's dementia
US5328915A (en) 1992-09-17 1994-07-12 E. I. Du Pont De Nemours And Company Arthropodicidal amidrazone ureas
SI9300616A (en) 1992-11-27 1994-06-30 Wellcome Found Enzyme inhibitors
GB9418912D0 (en) 1994-09-20 1994-11-09 Fisons Corp Pharmaceutically active compounds
WO1996014842A1 (en) 1994-11-15 1996-05-23 Merck & Co., Inc. Substituted heterocycles as inhibitors of nitric oxide synthase
DE4442116A1 (en) 1994-11-25 1996-05-30 Cassella Ag 2-amino-1,3-thiazines as inhibitors of nitric oxide synthase
WO1996018607A1 (en) 1994-12-12 1996-06-20 Chugai Seiyaku Kabushiki Kaisha Aniline derivative having the effect of inhibiting nitrogen monoxide synthase
JPH08333258A (en) 1994-12-14 1996-12-17 Japan Tobacco Inc Thiazine or thiazepine derivative and nitrogen monoxide synthetase inhibitor containing the compound
DE4444930A1 (en) 1994-12-16 1996-06-27 Cassella Ag 2-amino-1,3-thiazepines and their use as inhibitors of nitric oxide synthase
TW372967B (en) * 1994-12-27 1999-11-01 Kanebo Ltd 1,4 benzoxazine derivative, pharmaceutical composition containing the same and use thereof
EP0843661B1 (en) 1995-08-11 2002-03-27 Pfizer Inc. (1s,2s)-1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidin-1-yl)-1-propanolmethanesulfonate trihydrate
JPH0967355A (en) 1995-08-31 1997-03-11 Tokyo Tanabe Co Ltd Thiazine derivative, thiazole derivative and their production
NO307879B1 (en) 1995-09-18 2000-06-13 Sankyo Co New urea derivatives with ACAT inhibitory activity and pharmaceuticals containing them
JPH11513679A (en) 1995-10-17 1999-11-24 アストラ・フアーマシユウテイカルズ・リミテツド Drug-active quinazoline compounds
KR20000005388A (en) 1996-04-13 2000-01-25 니콜라스 피터 비가르트 (니크 비가르트), 콜린 레드롭 Aminoisoquinolines and aminothienopyridine derivatives and their use as anti-inflammatory agents
US6096753A (en) 1996-12-05 2000-08-01 Amgen Inc. Substituted pyrimidinone and pyridone compounds and methods of use
US5952374A (en) 1997-09-29 1999-09-14 Protein Technologies International, Inc. Method for inhibiting the development of Alzheimer's disease and related dementias- and for preserving cognitive function
SE9703693D0 (en) 1997-10-10 1997-10-10 Astra Pharma Prod Novel combination
TW460460B (en) 1997-11-04 2001-10-21 Chugai Pharmaceutical Co Ltd Heterocyclic compounds having NOS inhibitory activities
US6294695B1 (en) 1998-03-26 2001-09-25 Mount Sinai School Of Medicine Of The City University Of New York Aminobenzoic acid derivatives having anti-tumorigenic activity methods of making and using the same
AUPP285898A0 (en) 1998-04-07 1998-04-30 Fujisawa Pharmaceutical Co., Ltd. Amido derivatives
SE9802333D0 (en) 1998-06-29 1998-06-29 Astra Pharma Prod Novel combination
US7375125B2 (en) 1999-08-04 2008-05-20 Ore Pharmaceuticals, Inc. Melanocortin-4 receptor binding compounds and methods of use thereof
MX226123B (en) 1999-09-17 2005-02-07 Millennium Pharm Inc BENZAMIDES AND RELATED INHIBITORS OF FACTOR Xa.
US20030060487A1 (en) 2000-04-12 2003-03-27 Bamdad R. Shoshana Treatment of neurodegenerative disease
EP1283039A4 (en) 2000-05-19 2007-05-30 Takeda Pharmaceutical -secretase inhibitors
US6420566B2 (en) 2000-06-09 2002-07-16 Aventis Pharma S.A. Pharmaceutical compositions containing a 4, 5-dihydro-1, 3-thiazol-2-ylamine derivative, novel derivatives and preparation thereof
US6713276B2 (en) 2000-06-28 2004-03-30 Scios, Inc. Modulation of Aβ levels by β-secretase BACE2
WO2002062766A2 (en) 2001-02-07 2002-08-15 Millennium Pharmaceuticals, Inc. Melanocortin-4 receptor binding compounds and methods of use thereof
AU2002256418A1 (en) 2001-04-27 2002-11-11 Vertex Pharmaceuticals Incorporated Inhibitors of bace
US6562783B2 (en) 2001-05-30 2003-05-13 Neurologic, Inc. Phosphinylmethyl and phosphorylmethyl succinic and glutauric acid analogs as β-secretase inhibitors
BR0214035A (en) 2001-11-08 2005-04-26 Elan Pharm Inc Compound
BR0206368A (en) 2001-11-09 2004-02-10 Aventis Pharma Sa Use of 2-amino-4-pyridylmethyl thiazoline derivatives as inductively no synthase inhibitors
AU2002358874B2 (en) 2001-11-09 2007-09-06 Aventis Pharma S.A. 2-amino-4-heteroarylethyl thiazoline derivatives and their use an inhibitors of inducible no-synthase
RU2004117526A (en) 2001-11-09 2005-04-10 Авентис Фарма С.А. (Fr) APPLICATION OF 2-AMINOTIAZOLINE DERIVATIVES AS INHIBITORS OF INDUSTRIAL NO-SYNTHASE
US7271266B2 (en) 2002-03-28 2007-09-18 Merck & Co., Inc. Substituted 2,3-diphenyl pyridines
PL372695A1 (en) 2002-06-19 2005-07-25 Solvay Pharmaceuticals Gmbh Medicament for the treatment of diseases requiring inhibition or a reduction in the activity of ph value-regulating bicarbonate transporter proteins
AU2003249983A1 (en) 2002-07-18 2004-02-09 Actelion Pharmaceuticals Ltd Piperidines useful for the treatment of central nervous system disorders
WO2004014843A1 (en) 2002-08-09 2004-02-19 Takeda Chemical Industries, Ltd. Substituted amino compounds and use thereof
TW200502221A (en) 2002-10-03 2005-01-16 Astrazeneca Ab Novel lactams and uses thereof
JP2004149429A (en) 2002-10-29 2004-05-27 Takeda Chem Ind Ltd Indole compound and application thereof
JP2006096665A (en) 2002-10-29 2006-04-13 Ono Pharmaceut Co Ltd Therapeutic agent for spinal canal stenosis
WO2004043916A1 (en) 2002-11-12 2004-05-27 Merck & Co., Inc. Phenylcarboxamide beta-secretase inhibitors for the treatment of alzheimer's disease
RU2252936C2 (en) 2002-12-05 2005-05-27 Институт физиологически активных веществ РАН S-substituted [(hetero)aryl]alkylisothioureas, production thereof, pharmaceutical composition, investigation of glutamatergic system, treatment methods (variants)
MXPA05011503A (en) 2003-04-25 2006-05-31 Johnson & Johnson C-fms kinase inhibitors.
GB0324498D0 (en) 2003-07-21 2003-11-26 Aventis Pharma Inc Heterocyclic compounds as P2X7 ion channel blockers
US7338950B2 (en) 2003-10-07 2008-03-04 Renovis, Inc. Amide compounds as ion channel ligands and uses thereof
US7763609B2 (en) 2003-12-15 2010-07-27 Schering Corporation Heterocyclic aspartyl protease inhibitors
US7592348B2 (en) 2003-12-15 2009-09-22 Schering Corporation Heterocyclic aspartyl protease inhibitors
AU2004299040A1 (en) 2003-12-15 2005-06-30 Pharmacopeia, Inc. Heterocyclic aspartyl protease inhibitors
US20070203147A1 (en) 2004-03-30 2007-08-30 Coburn Craig A 2-Aminothiazole Compounds Useful As Aspartyl Protease Inhibitors
EP1747218A2 (en) 2004-04-30 2007-01-31 Schering Corporation Neuropeptide receptor modulators
AU2005264917A1 (en) 2004-06-16 2006-01-26 Wyeth Diphenylimidazopyrimidine and -imidazole amines as inhibitors of B-secretase
AU2005277283A1 (en) 2004-08-23 2006-03-02 Merck Sharp & Dohme Corp. Fused triazole derivatives as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
EP1791818A1 (en) 2004-09-14 2007-06-06 The Genetics Company, Inc. Hydrazone derivatives and their use as beta secretase inhibitors
WO2006041404A1 (en) 2004-10-15 2006-04-20 Astrazeneca Ab Substituted amino-compounds and uses thereof
US20090062282A1 (en) 2004-10-15 2009-03-05 Astrazeneca Ab Substituted Amino-Pyrimidones and Uses Thereof
JP2008523139A (en) 2004-12-14 2008-07-03 アストラゼネカ・アクチエボラーグ Substituted aminopyridines and uses thereof
NZ556546A (en) 2005-01-07 2011-02-25 Synta Pharmaceuticals Corp Compounds for inflammation and immune-related uses
WO2006076284A2 (en) 2005-01-14 2006-07-20 Wyeth AMINO-IMIDAZOLONES FOR THE INHIBITION OF ß-SECRETASE
AU2006214627A1 (en) 2005-02-14 2006-08-24 Wyeth Azolylacylguanidines as beta-secretase inhibitors
WO2006088705A1 (en) 2005-02-14 2006-08-24 Wyeth Terphenyl guanidines as [beta symbol] -secretase inhibitors
WO2006088694A1 (en) 2005-02-14 2006-08-24 Wyeth SUBSTITUTED THIENYL AND FURYL ACYLGUANIDINES AS β-SECRETASE MODULATORS
MX2007011234A (en) 2005-03-14 2007-11-12 Transtech Pharma Inc Benzazole derivatives, compositions, and methods of use as b-secretase inhibitors.
EP1896032B1 (en) 2005-06-14 2012-10-31 Merck Sharp & Dohme Corp. The preparation and use of compounds as protease inhibitors
KR20080025079A (en) 2005-06-14 2008-03-19 쉐링 코포레이션 Aspartyl protease inhibitors
AU2006259675A1 (en) 2005-06-14 2006-12-28 Schering Corporation Aspartyl protease inhibitors
NZ564222A (en) 2005-06-14 2011-10-28 Taigen Biotechnology Co Ltd Pyrimidine compounds
WO2007002220A2 (en) 2005-06-21 2007-01-04 Bristol-Myers Squibb Company Aminoacetamide acyl guanidines as beta-secretase inhibitors
JP2009500329A (en) 2005-06-30 2009-01-08 ワイス Amino-5- (6 membered) heteroarylimidazolone compounds and their use for β-selectase modulation
TW200738683A (en) 2005-06-30 2007-10-16 Wyeth Corp Amino-5-(5-membered)heteroarylimidazolone compounds and the use thereof for β-secretase modulation
TW200730523A (en) 2005-07-29 2007-08-16 Wyeth Corp Cycloalkyl amino-hydantoin compounds and use thereof for β-secretase modulation
EP1915339A1 (en) * 2005-08-11 2008-04-30 Boehringer Ingelheim International GmbH Beta-secretase inhibitors for use in the treatment of alzheimer's disease
PE20070461A1 (en) 2005-09-26 2007-05-10 Wyeth Corp AMINO-5- [4- (DIFLUOROMETOXI) PHENYL] -5-PHENYLIMIDAZOLONE COMPOUNDS AS B-SECRETASE INHIBITORS
BRPI0617852A2 (en) 2005-10-25 2011-08-09 Shionogi & Co aminodihydrothiazine derivatives as well as compositions containing them
EP1951682A4 (en) 2005-11-15 2011-06-15 Astrazeneca Ab Novel 2-aminopyrimidinone or 2-aminopyridinone derivatives and their use
TW200804290A (en) 2005-11-15 2008-01-16 Astrazeneca Ab Compounds and uses thereof
EP1951680A4 (en) 2005-11-15 2011-08-10 Astrazeneca Ab Novel 2-aminopyrimidinone derivatives and their use
TW200734311A (en) 2005-11-21 2007-09-16 Astrazeneca Ab New compounds
CN101360716A (en) 2005-11-21 2009-02-04 阿斯利康(瑞典)有限公司 Novel 2-amino-imidazole-4-one compounds and their use in the manufacture of a medicament to be used in the treatment of cognitive impairment, alzheimer s disease, neurodegeneration and dementia
JP2009520027A (en) 2005-12-19 2009-05-21 ワイス 2-Amino-5-piperidinylimidazolone compounds and their use in the regulation of β-secretase
AR058381A1 (en) 2005-12-19 2008-01-30 Astrazeneca Ab COMPOUNDS DERIVED FROM 2-AMINOPIRIDIN-4-ONAS AND A PHARMACEUTICAL COMPOSITION
UY30118A1 (en) 2006-01-31 2007-06-29 Tanabe Seiyaku Co AMIS TRISUSTITUDE COMPUTER
WO2007092854A2 (en) 2006-02-06 2007-08-16 Janssen Pharmaceutica N.V. 2-AMINO-QUINOLINE DERIVATIVES USEFUL AS INHIBITORS OF β-SECRETASE (BACE)
WO2007092846A2 (en) 2006-02-06 2007-08-16 Janssen Pharmaceutica N.V. 2-AMINO-3,4-DIHYDRO-QUINOLINE DERIVATIVES USEFUL AS INHIBITORS OF β-SECRETASE (BACE)
JP2009532464A (en) 2006-04-05 2009-09-10 アストラゼネカ・アクチエボラーグ 2-Aminopyrimidin-4-one and its use for treating or preventing Aβ-related pathologies
TW200808751A (en) 2006-04-13 2008-02-16 Astrazeneca Ab New compounds
SI2021335T1 (en) 2006-04-20 2011-09-30 Janssen Pharmaceutica Nv Heterocyclic compounds as inhibitors of c-fms kinase
AU2007258435A1 (en) 2006-06-12 2007-12-21 Schering Corporation Heterocyclic aspartyl protease inhibitors
US20080021217A1 (en) 2006-07-20 2008-01-24 Allen Borchardt Heterocyclic inhibitors of rho kinase
TW200817406A (en) 2006-08-17 2008-04-16 Wyeth Corp Imidazole amines as inhibitors of β-secretase
MX2009006227A (en) 2006-12-12 2009-06-22 Schering Corp Aspartyl protease inhibitors containing a tricyclic ring system.
WO2008073365A1 (en) 2006-12-12 2008-06-19 Schering Corporation Aspartyl protease inhibitors
TW200831080A (en) 2006-12-15 2008-08-01 Irm Llc Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
WO2008098857A1 (en) 2007-02-15 2008-08-21 F. Hoffmann-La Roche Ag 2-aminooxazolines as taar1 ligands
WO2008133273A1 (en) * 2007-04-24 2008-11-06 Shionogi & Co., Ltd. Pharmaceutical composition for treatment of alzheimer's disease
AU2008245082B8 (en) 2007-04-24 2012-09-13 Shionogi & Co., Ltd. Aminodihydrothiazine derivatives substituted with a cyclic group
GB0713686D0 (en) 2007-07-13 2007-08-22 Addex Pharmaceuticals Sa New compounds 2
JP4846769B2 (en) 2007-07-30 2011-12-28 田辺三菱製薬株式会社 Pharmaceutical composition
WO2009064418A1 (en) 2007-11-14 2009-05-22 Amgen Inc. Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use
US8158620B2 (en) 2008-01-18 2012-04-17 Eisai R&D Management Co., Ltd. Fused aminodihydrothiazine derivatives
NZ586831A (en) 2008-01-28 2012-02-24 Janssen Pharmaceutica Nv 6-substituted-thio-2-amino-quinoline derivatives useful as inhibitors of beta-secretase (bace)
US7786116B2 (en) 2008-01-29 2010-08-31 Janssen Pharmaceutica N.V. 2-amino-quinoline derivatives useful as inhibitors of β-secretase (BACE)
EP2252595B1 (en) 2008-02-01 2014-03-26 Takeda Pharmaceutical Company Limited Oxim derivatives as hsp90 inhibitors
BRPI0907563A2 (en) 2008-02-18 2015-08-04 Hoffmann La Roche 4,5-Dihydroxazol-2-ylamine derivatives
PE20091834A1 (en) 2008-04-22 2009-12-19 Schering Corp 2-IMINO-3-METHYLPYRROLOOPYRIMIDINONE THIOPHENYL-SUBSTITUTED COMPOUNDS AS BACE-1 INHIBITORS AND COMPOSITIONS CONTAINING THEM
TWI431004B (en) 2008-05-02 2014-03-21 Lilly Co Eli Bace inhibitors
NZ589590A (en) 2008-06-13 2012-05-25 Shionogi & Co Sulfur-containing heterocyclic derivative having beta-secretase-inhibiting activity
CA2731209A1 (en) 2008-07-28 2010-02-04 Eisai R&D Management Co., Ltd. Spiroaminodihydrothiazine derivatives
WO2010013302A1 (en) 2008-07-28 2010-02-04 エーザイ・アール・アンド・ディー・マネジメント株式会社 Spiroaminodihydrothiazine derivative
EP2312945A4 (en) 2008-08-13 2012-05-09 Merck Sharp & Dohme Purine derivatives for treatment of alzheimer's disease
US8685972B2 (en) 2008-08-13 2014-04-01 Merck Sharp & Dohme Corp. Pyrimidine derivatives for treatment of alzheimer's disease
AR073406A1 (en) 2008-09-30 2010-11-03 Eisai R&D Man Co Ltd AMINODIHYDROTIAZINES FUSED WITH TETRAHYDROPIRANS, INHIBITORS OF BACE1 AND THE PRODUCTION OF ABETA AMILOID, PHARMACEUTICAL COMPOSITIONS CONTAINING THEMSELVES AND USES OF THE SAME FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES, TALES.
JPWO2010047372A1 (en) 2008-10-22 2012-03-22 塩野義製薬株式会社 2-Aminopyrimidin-4-one and 2-aminopyridine derivatives having BACE1 inhibitory activity
US20100125087A1 (en) 2008-11-14 2010-05-20 Astrazeneca Ab New compounds 575
US20100125081A1 (en) 2008-11-14 2010-05-20 Astrazeneca Ab New compounds 574
TW201020244A (en) 2008-11-14 2010-06-01 Astrazeneca Ab New compounds
TW201040141A (en) 2009-03-31 2010-11-16 Shionogi & Co Isothiourea derivatives or isourea derivatives having BACE1 inhibitory activity
KR101123178B1 (en) 2009-04-09 2012-06-13 (주)에스메디 2-aryl benzothiophene derivatives or pharmaceutically acceptable salts thereof, preparation method thereof, and phrmaceutical composition for the diagnosis or treatment of degenerative brain disease containing the same as an active ingredient
WO2010129864A2 (en) 2009-05-07 2010-11-11 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for studying, imaging, and treating pain
US8461160B2 (en) 2009-05-08 2013-06-11 Hoffmann-La Roche, Inc. Dihydropyrimidinones
AR077277A1 (en) 2009-07-09 2011-08-17 Lilly Co Eli BICYCLE COMPOUNDS (1,3) TIAZIN-2-AMINA PHARMACEUTICAL FORMULATION THAT INCLUDES IT AND ITS USE FOR THE MANUFACTURE OF A USEFUL MEDICINAL PRODUCT FOR THE TREATMENT OF ALZHEIMER'S DISEASE
GB0912778D0 (en) 2009-07-22 2009-08-26 Eisai London Res Lab Ltd Fused aminodihydro-oxazine derivatives
GB0912777D0 (en) 2009-07-22 2009-08-26 Eisai London Res Lab Ltd Fused aminodihydropyrimidone derivatives
UY32799A (en) 2009-07-24 2011-02-28 Novartis Ag DERIVATIVES OF OXAZINE AND ITS USE IN THE TREATMENT OF NEUROLOGICAL DISORDERS
US8188079B2 (en) 2009-08-19 2012-05-29 Hoffman-La Roche Inc. 3-amino-5-phenyl-5,6-dihydro-2H-[1,4]oxazines
US20110065695A1 (en) 2009-09-11 2011-03-17 Jeremy Beauchamp Use of aminodihydrothiazines for the treatment or prevention of diabetes
WO2011044187A1 (en) 2009-10-08 2011-04-14 Schering Corporation Iminothiadiazine dioxide compounds as bace inhibitors, compositions, and their use
UA108363C2 (en) 2009-10-08 2015-04-27 IMINOTIADIASIADIOXIDE OXIDES AS BACE INHIBITORS, COMPOSITIONS THEREOF AND THEIR APPLICATIONS
WO2011044185A2 (en) 2009-10-08 2011-04-14 Schering Corporation Pentafluorosulfur imino heterocyclic compounds as bace-1 inhibitors, compositions, and their use
EP2485590B1 (en) 2009-10-08 2015-01-07 Merck Sharp & Dohme Corp. Pentafluorosulfur imino heterocyclic compounds as bace-1 inhibitors, compositions, and their use
US8354441B2 (en) 2009-11-11 2013-01-15 Hoffmann-La Roche Inc. Oxazoline derivatives
EP2500344A4 (en) 2009-11-13 2013-05-01 Shionogi & Co Aminothiazine or aminooxazine derivative having amino linker
EP2509983B1 (en) 2009-11-16 2014-09-17 Merck Sharp & Dohme Corp. FUSED TRICYCLIC COMPOUNDS WITH ADENOSINE A2a RECEPTOR ANTAGONIST ACTIVITY
WO2011070781A1 (en) 2009-12-09 2011-06-16 塩野義製薬株式会社 Substituted aminothiazine derivative
JP5554346B2 (en) 2009-12-09 2014-07-23 塩野義製薬株式会社 Pharmaceutical composition for treating or preventing Alzheimer's disease containing a sulfur-containing heterocyclic derivative
US7964594B1 (en) * 2009-12-10 2011-06-21 Hoffmann-La Roche Inc. Amino oxazine derivatives
CA2783958A1 (en) 2009-12-11 2011-06-16 Shionogi & Co., Ltd. Oxazine derivative
US20120245155A1 (en) 2009-12-11 2012-09-27 Shionogi & Co., Ltd. Fused heterocyclic compound having amino group
UA103272C2 (en) 2009-12-11 2013-09-25 Ф. Хоффманн-Ля Рош Аг 2-amino-5,5-difluoro-5,6-dihydro-4h-[1,3]oxazines as bace1 and/or bace2 inhibitors
WO2011077726A1 (en) 2009-12-24 2011-06-30 塩野義製薬株式会社 4-amino-1,3-thiazine or oxazine derivative
NZ600136A (en) 2009-12-31 2013-09-27 Novartis Ag Pyrazine derivatives and their use in the treatment of neurological disorders
US8673894B2 (en) 2010-05-07 2014-03-18 Hoffmann-La Roche Inc. 2,5,6,7-tetrahydro-[1,4]oxazepin-3-ylamine or 2,3,6,7-tetrahydro-[1,4]oxazepin-5-ylamine compounds
EP2580200B1 (en) 2010-06-09 2016-09-14 Janssen Pharmaceutica, N.V. 5,6-dihydro-2h-[1,4]oxazin-3-yl-amine derivatives useful as inhibitors of beta-secretase (bace)
JP2013531644A (en) 2010-06-09 2013-08-08 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 5-Amino-3,6-dihydro-1H-pyrazin-2-one derivatives useful as inhibitors of β-secretase (BACE)
US20130102618A1 (en) 2010-06-28 2013-04-25 Janssen Pharmaceutica Nv 3-amino-5,6-dihydro-1h-pyrazin-2-one derivatives useful for the treatment of alzheimer's disease and other forms of dementia
CA2771928C (en) 2010-07-13 2013-08-06 Novartis Ag Oxazine derivatives and their use in the treatment of neurological disorders
US8815881B2 (en) 2010-08-09 2014-08-26 Hoffmann-La Roche Inc. 1,4,5,6-tetrahydro-pyrimidin-2-ylamine compounds
US8609660B2 (en) 2010-09-22 2013-12-17 Janssen Pharmaceutica Nv 4,7-dihydro-pyrazolo[1,5-a]pyrazin-6-ylamine derivatives useful as inhibitors of beta-secretase (BACE)
US8927721B2 (en) 2010-10-29 2015-01-06 Shionogi & Co., Ltd. Naphthyridine derivative
US9018219B2 (en) 2010-10-29 2015-04-28 Shionogi & Co., Ltd. Fused aminodihydropyrimidine derivative
SG191097A1 (en) 2010-12-22 2013-08-30 Janssen Pharmaceutica Nv 5,6-DIHYDRO-IMIDAZO[1,2-a]PYRAZIN-8-YLAMINE DERIVATIVES USEFUL AS INHIBITORS OF BETA-SECRETASE (BACE)
GB201100181D0 (en) 2011-01-06 2011-02-23 Eisai Ltd Fused aminodihydrothiazine derivatives
US8524897B2 (en) 2011-01-12 2013-09-03 Novartis Ag Crystalline oxazine derivative
EA201391029A1 (en) 2011-01-12 2014-01-30 Новартис Аг OXAZIN DERIVATIVES AND THEIR APPLICATION IN THE TREATMENT OF NEUROLOGICAL DISORDERS
EP2663308A1 (en) 2011-01-13 2013-11-20 Novartis AG Bace-2 inhibitors for the treatment of metabolic disorders
SI2663561T1 (en) 2011-01-13 2016-07-29 Novartis Ag Novel heterocyclic derivatives and their use in the treatment of neurological disorders
US9242943B2 (en) 2011-01-18 2016-01-26 Siena Biotech S.P.A. 1,4 oxazines as BACE1 and/or BACE2 inhibitors
GB201101140D0 (en) 2011-01-21 2011-03-09 Eisai Ltd Fused aminodihydrothiazine derivatives
GB201101139D0 (en) 2011-01-21 2011-03-09 Eisai Ltd Fused aminodihydrothiazine derivatives
US8399459B2 (en) 2011-02-02 2013-03-19 Hoffmann-La Roche Inc. 1,4 oxazines as BACE1 and/or BACE2 inhibitors
US8404680B2 (en) 2011-02-08 2013-03-26 Hoffmann-La Roche Inc. N-[3-(5-amino-3,3a,7,7a-tetrahydro-1H-2,4-dioxa-6-aza-inden-7-yl)-phenyl]-amides as BACE1 and/or BACE2 inhibitors
US20130040971A1 (en) 2011-02-14 2013-02-14 Boehringer Ingelheim International Gmbh 6-cycloalkyl-pyrazolopyrimidinones for the treatment of cns disorders
US8809345B2 (en) 2011-02-15 2014-08-19 Boehringer Ingelheim International Gmbh 6-cycloalkyl-pyrazolopyrimidinones for the treatment of CNS disorders
US8815841B2 (en) 2011-02-18 2014-08-26 Hoffmann-La Roche Inc. 1,4-Oxazepines as BACE1 and/or BACE2 inhibitors
WO2012117027A1 (en) 2011-03-01 2012-09-07 Janssen Pharmaceutica Nv 6,7-dihydro-pyrazolo[1,5-a]pyrazin-4-ylamine derivatives useful as inhibitors of beta-secretase (bace)
US9067924B2 (en) 2011-03-04 2015-06-30 Hoffmann-La Roche Inc. 1,4 thiazepines/sulfones as BACE1 and/or BACE2 inhibitors
CA2825620C (en) 2011-03-09 2019-04-23 Janssen Pharmaceutica Nv 3,4-dihydro-pyrrolo[1,2-a]pyrazin-1-ylamine derivatives useful as inhibitors of beta-secretase (bace)
US8748418B2 (en) 2011-03-18 2014-06-10 Hoffmann-La Roche Inc. 1,4-oxazepines as BACE1 and/or BACE2 inhibitors
US8877744B2 (en) 2011-04-04 2014-11-04 Hoffmann-La Roche Inc. 1,4-Oxazepines as BACE1 and/or BACE2 inhibitors
US8754075B2 (en) 2011-04-11 2014-06-17 Hoffmann-La Roche Inc. 1,3-oxazines as BACE1 and/or BACE2 inhibitors
EP2703399A4 (en) 2011-04-26 2014-10-15 Shionogi & Co Oxazine derivative and bace 1 inhibitor containing same
WO2012147762A1 (en) 2011-04-26 2012-11-01 塩野義製薬株式会社 Pyridine derivative and bace-1 inhibitor containing same
US8785436B2 (en) 2011-05-16 2014-07-22 Hoffmann-La Roche Inc. 1,3-oxazines as BACE 1 and/or BACE2 inhibitors
US8604024B2 (en) 2011-05-24 2013-12-10 Bristol-Myers Squibb Company Compounds for the reduction of beta-amyloid production
WO2012162334A1 (en) 2011-05-24 2012-11-29 Bristol-Myers Squibb Company Compounds for the reduction of beta-amyloid production
US9079919B2 (en) 2011-05-27 2015-07-14 Hoffmann-La Roche Inc. Spiro-[1,3]-oxazines and spiro-[1,4]-oxazepines as BACE1 and/or BACE2 inhibitors
JP2012250933A (en) 2011-06-03 2012-12-20 Shionogi & Co Ltd Pharmaceutical composition containing oxazine derivative for treating or preventing alzheimer's disease
KR20140041687A (en) 2011-06-07 2014-04-04 에프. 호프만-라 로슈 아게 Halogen-alkyl-1,3 oxazines as bace1 and/or bace2 inhibitors
US9073909B2 (en) 2011-06-07 2015-07-07 Hoffmann-La Roche Inc. [1,3]oxazines
UY34278A (en) 2011-08-25 2013-04-05 Novartis Ag NEW NOXEDINE DERIVATIVES OF OXAZINE AND ITS USE IN THE TREATMENT OF DISEASES
US20130073953A1 (en) 2011-09-21 2013-03-21 Timothy Onyenobi News headline screenshot viewing system
UA111749C2 (en) 2011-12-05 2016-06-10 Янссен Фармацевтика Нв 6-difluoromethyl-5,6-dihydro-2H- [1,4] OXASINE-3-AMINE DERIVATIVES
MX357383B (en) 2011-12-06 2018-07-06 Janssen Pharmaceutica Nv 5-(3-aminophenyl)-5-alkyl-5,6-dihydro-2h-[1,4]oxazin-3-amine derivatives.
SG11201403956VA (en) 2012-01-26 2014-10-30 Hoffmann La Roche Fluoromethyl-5,6-dihydro-4h-[1,3]oxazines
US8338413B1 (en) 2012-03-07 2012-12-25 Novartis Ag Oxazine derivatives and their use in the treatment of neurological disorders
CA2867851A1 (en) 2012-03-20 2013-09-26 Elan Pharmaceuticals, Inc. Spirocyclic dihydro-thiazine and dihydro-oxazine bace inhibitors, and compositions and uses thereof
MA37763B1 (en) 2012-06-26 2017-05-31 Hoffmann La Roche Difluoro-hexahydro-cyclopentaoxazinyl and difluoro-hexahydro-benzooxazinyls as bace1 inhibitors
WO2014010748A1 (en) 2012-07-10 2014-01-16 Shionogi & Co., Ltd. Cyclopropane derivative having bace1 inhibiting activity
JP2014101354A (en) 2012-10-24 2014-06-05 Shionogi & Co Ltd Oxazin derivative having bace1 antagonism
EP2912035A4 (en) 2012-10-24 2016-06-15 Shionogi & Co Dihydrooxazine or oxazepine derivatives having bace1 inhibitory activity
JP2014101353A (en) 2012-10-26 2014-06-05 Shionogi & Co Ltd Pharmaceutical composition for alzheimer's disease medical treatment or prevention including oxazin derivative
US9475784B2 (en) 2012-12-19 2016-10-25 Bristol-Myers Squibb Company 4,6-diarylaminothiazines as BACE1 inhibitors and their use for the reduction of beta-amyloid production
US20150376172A1 (en) 2013-01-22 2015-12-31 Thomas Woltering Fluoro-[1,3]oxazines as bace1 inhibitors
AU2014223334C1 (en) 2013-03-01 2018-10-18 Amgen Inc. Perfluorinated 5,6-dihydro-4H-1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use
CN105164121A (en) 2013-03-08 2015-12-16 美国安进公司 Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use
JP6155537B2 (en) 2013-03-22 2017-07-05 エルジー・ケム・リミテッド CONDUCTIVE PATTERN LAMINATE, MANUFACTURING METHOD THEREOF, AND ELECTRONIC DEVICE AND TOUCH SCREEN CONTAINING CONDUCTIVE PATTERN LAMINATE
KR102247765B1 (en) 2013-04-11 2021-05-06 에프. 호프만-라 로슈 아게 Bace1 inhibitors
WO2015132141A1 (en) 2014-03-03 2015-09-11 F. Hoffmann-La Roche Ag 1,3-oxazine-2-amine derivatives acting as bace inhibitors for the treatment of alzheimer's disease
TW201623295A (en) 2014-04-11 2016-07-01 塩野義製藥股份有限公司 Dihydrothiazine and dihydrooxazine derivatives having BACE1 inhibitory activity
WO2016001266A1 (en) 2014-07-04 2016-01-07 F. Hoffmann-La Roche Ag Fluoro-[1,3]oxazines as bace1 inhibitors
WO2016012384A1 (en) 2014-07-22 2016-01-28 F. Hoffmann-La Roche Ag Trifluormethyloxazine amidines as bace1 inhibitors
WO2017061534A1 (en) 2015-10-08 2017-04-13 Shionogi & Co., Ltd. Dihydrothiazine derivatives
JP2017071603A (en) 2015-10-09 2017-04-13 塩野義製薬株式会社 Pharmaceutical composition comprising dihydrothiazine or dihydrooxazine derivative
JP7177773B2 (en) 2016-12-15 2022-11-24 アムジエン・インコーポレーテツド Oxazine derivatives as beta-secretase inhibitors and methods of use
MA54101A (en) 2016-12-15 2021-10-27 Amgen Inc BICYCLIC THIAZINE AND OXAZINE DERIVATIVES AS BETA-SECRETASE INHIBITORS AND METHODS OF USE

Also Published As

Publication number Publication date
US8999980B2 (en) 2015-04-07
EP2511268B1 (en) 2016-07-13
EP2511268A4 (en) 2013-04-17
TWI488852B (en) 2015-06-21
JPWO2011071135A1 (en) 2013-04-22
AU2010328975A1 (en) 2012-06-14
ZA201203777B (en) 2013-08-28
MX2012006491A (en) 2012-07-03
US9290466B2 (en) 2016-03-22
JP2016028057A (en) 2016-02-25
UA110467C2 (en) 2016-01-12
US20160159757A1 (en) 2016-06-09
US20120245157A1 (en) 2012-09-27
ZA201303603B (en) 2015-02-25
US9656974B2 (en) 2017-05-23
AU2010328975B2 (en) 2015-01-22
US20150166491A1 (en) 2015-06-18
CA2783958A1 (en) 2011-06-16
EP2511268A1 (en) 2012-10-17
ES2590038T5 (en) 2021-10-19
WO2011071135A1 (en) 2011-06-16
EP2511268B2 (en) 2021-02-17
CN102834384A (en) 2012-12-19
KR20120104570A (en) 2012-09-21
BR112012013854A2 (en) 2019-09-24
TW201127833A (en) 2011-08-16
RU2012129168A (en) 2014-01-20

Similar Documents

Publication Publication Date Title
ES2590038T3 (en) Oxazine derivative
US20120245155A1 (en) Fused heterocyclic compound having amino group
ES2476027T3 (en) Aminodihydrotriazine derivatives
US8883779B2 (en) Oxazine derivatives and a pharmaceutical composition for inhibiting BACE1 containing them
US20120245154A1 (en) Substituted aminothiazine derivative
US20120238557A1 (en) Aminothiazine or aminooxazine derivative having amino linker
AR068950A1 (en) BICYCLE HETEROCICLE DERIVATIVES AND METHODS OF USE OF THE SAME
WO2012147762A1 (en) Pyridine derivative and bace-1 inhibitor containing same
JP2010521528A (en) Indolizine and its aza-like derivatives as CNS active compounds
US20130217705A1 (en) Naphthyridine derivative
RU2012149633A (en) ORGANIC COMPOUNDS
ES2584684T3 (en) Betulin propenoate derivatives
ME01564B (en) Addition salts of amines containing hydroxyl and/or carboxylic groups with amino nicotinic acid derivatives as dhodh inhibitors
CN109790135A (en) For treating or preventing compound, composition and the method for symptom relevant to gout or hyperuricemia
TW200804257A (en) Inhibitors of histone deacetylase for the treatment of disease
ES2362683T3 (en) METHANOSULFONATE OF 4 - [(3-FLUOROPHENOXY) PHENYLMETILE] PIPERIDINE: USES, SYNTHESIS PROCEDURES AND PHARMACEUTICAL COMPOSITIONS.
TW200413313A (en) 2,4-substituted indoles
ES2566755T3 (en) FXa inhibitors with cyclic amidoxime or cyclic amidrazone as a P4 subunit, procedures for their preparations, and pharmaceutical compositions and derivatives thereof
EP3564242B1 (en) Compound for selectively inhibiting kinase and use thereof
CN107530349A (en) As A2Alkynylamino formic acid esters/trans carbamate of the xanthine substitution of B antagonists
FR2876692A1 (en) 2-AMIDO-4-PHENYLTHIAZOLE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE
WO2008051637A2 (en) Pyridazinone compounds
JP2020023570A (en) 2,6-di-substituted pyridine derivative
TW201011042A (en) [1,2,4]thiadiazine 1,1-dioxide compounds
TW200920362A (en) Alkylsulfone derivatives